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Pollution of ground water from hazardous waste sites,' explosions at
chemical plants, and other modem tragedies that release toxic substances
into the environment have prompted the development of toxic tort litiga-
tion.2 Americans have been exposed to toxic substances in their homes,
3
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1. Some studies have estimated that over 90% of all hazardous chemical waste pro-
duced in the United States has been disposed of improperly. SENATE COMM. ON ENV'T AND
PUB. WORKS, S. REP. No. 848, 96th Cong., 2d Sess. 3 (1980) (citing Environmental Protection
Agency (EPA) estimates). The EPA has also estimated that as many as 2000 of the 30,000 -
50,000 waste disposal sites in this country pose a potential public health or environmental
threat. Jerold Oshinsky, Insurance Coverage Issues in Delayed-Manifestation Bodily Injury
and Property Damage Claims Arising from Asbestos, Hazardous Substances, and Environmental
Impairment Litigation, in FIFrH ANNUAL Toxic TORT ADVOCACY INSTITUTE 214 (Sheila
Birnbaum & David Gross eds., 1988).
2. Toxic substances are any chemical, biological, biochemical, or radioactive materials
that cause immediate or long-term harm to people, animals, or the environment, such as asbes-
tos, Agent Orange, benzene, diethylstilbestrol (DES), dioxin, formaldehyde, radiation, and
vinyl chloride. Allan T. Slagel, Note, Medical Surveillance Damages: A Solution to the Inade-
quate Compensation of Toxic Tort Victims, 63 IND. L.J. 849, 849 n.1 (1988).
Toxic torts are legal claims for chronic illnesses attributed to toxic or hazardous sub-
stances. American Enter. Inst. for Pub. Policy Research, Toxic Torts. Proposals for Compen-
sating Victims of Hazardous Substances, Legislative Analysis, 98th Cong., 2d Sess. (1984)
[hereinafter AEI Analysis]. For a discussion of major characteristics of toxic torts see
MICHAEL DORE, LAW OF Toxic TORTS: LrIGATION/DEFENSE/INSURANCE § 2.02 (1987)
[hereinafter DORE, LAW OF Toxic TORTS].
3. In a typical scenario, a residential drinking water supply is contaminated by the re-
lease of toxic substances from nearby industrial or dump sites. See, eg., Merry v. Westing-
house Elec. Corp., 684 F. Supp. 847 (M.D. Pa. 1988); Ayers v. Jackson Township, 106 N.J.
[661]
at work,4 while serving in the military,5 and while going about their daily
lives. 6 Commentators overwhelmingly agree that the unique characteris-
tics and complexities of toxic exposure litigation render traditional tort
remedies inadequate to justly compensate victims of toxic exposure.
7
557, 565, 525 A.2d 287, 291 (1987); Habitants Against Landfill Toxicants v. City of York,
[1985] 15 Envtl. L. Rep. (Envtl. L. Inst.) 20,937, 20,937 (Pa. Ct. C.P. May 20, 1985). Resi-
dents have been exposed to toxic substances in their homes in other situations as well. See
Villari v. Terminix Int'l, Inc., 663 F. Supp. 727, 728 (E.D. Pa. 1987) (family exposed to harm-
ful chemicals when pest control business spilled Aldrin into their basement); In re Three Mile
Island Litig., 557 F. Supp. 96, 97 n.1 (M.D. Pa. 1982) (citizens exposed to radioactive material
as result of Three Mile Island nuclear power plant disaster); Burns v. Jaquays Mining Corp.,
156 Ariz. 375, 376, 752 P.2d 28, 29 (Ct. App. 1988) (residents of mobile home park exposed to
asbestos fiber when fiber was blown from adjacent asbestos mill into trailer park).
4. Exposure to asbestos in the workplace led to the filing of thousands of lawsuits
against the manufacturers of asbestos. The Johns-Manville Corporation, the largest asbestos
manufacturer, has been named as a defendant in over 20,000 lawsuits and predicts it will be
named in a total of more than 50,000 by the year 2000. AEI Analysis, supra note 2. Cases
dealing with asbestos-related employee claims include Herber v. Johns-Manville Corp., 785
F.2d 79 (3d Cir. 1986), and Mauro v. Owens-Coming Fiberglass, 225 N.J. Super. 196, 542
A.2d 16 (1988), affd sub nom. Mauro v. Raymark Indus., 116 N.J. 126, 561 A.2d 257 (1989).
Occupational exposure to hazardous substances other than asbestos has sparked litigation
as well. See, e.g., Hagerty v. L & L Marine Servs., Inc., 788 F.2d 315, modified, 797 F.2d 256
(5th Cir. 1986) (seaman accidentally soaked with toxic chemicals while on duty as tankerman);
Barth v. Firestone Tire & Rubber Co., 673 F. Supp. 1466 (N.D. Cal. 1987) (alleged exposure
to benzene while working at tire manufacturing plant). Recently, former and current workers
of the Rocky Flats nuclear weapons plant initiated litigation to secure, among other relief, the
creation of a defendant-funded medical surveillance fund to monitor the health consequences
of their occupational exposures to radioactive and nonradioactive hazardous substances.
Building & Constr. Trades Dep't v. Rockwell Int'l Corp., 756 F. Supp. 492 (D. Colo. 1991).
The Labor Department has determined that there are as many as 575,000 hazardous chemicals
being used in U.S. workplaces. ILC Adopts Texts Concerning Safety in Use of Chemicals in the
Workplace, Daily Rep. for Executives (BNA), at A-10 (June 26, 1990) [hereinafter ILC
Adopts Texts].
5. Military personnel have been exposed to radiation emitted by nuclear bombs, both
during actual wartime and during testing operations, and to chemicals such as the defoliant
Agent Orange. AEI Analysis, supra note 2, at 7-8. See, e.g., In re Agent Orange Prod. Liab.
Litig., 611 F. Supp. 1396, 1399-400 (E.D.N.Y. 1985), cert. denied, 487 U.S. 1234 (1986), affid
in relevant part, 818 F.2d 179, 183 (2d Cir. 1987).
6. For example, a December 28, 1991 New York City subway fire trapped hundreds of
'people during rush hour for about forty minutes while smoke and reportedly toxic polyvinyl-
chloride fumes flooded the area. Andrew Blum, Lifestyle Queries Roil Plaintiffs, NAT'L L.J.,
Mar. 11, 1991, at 3.
7. See William R. Ginsberg & Lois Weiss, Common Law Liability for Toxic Torts: A
Phantom Remedy, 9 HOFSTRA L. REv. 859 passim (1981); David Rosenberg, The Causal Con-
nection in Mass Exposure Cases: A "Public Law" Vision of the Tort System, 97 HARV. L. REV.
851, 859 (1984); Jeffrey Trauberman, Statutory Reform of "Toxic Torts" Relieving Legal,
Scientific, and Economic Burdens on the Chemical Victim, 7 HARV. ENVTL. L. REV. 177, 183
(1983); Brent Carson, Note, Increased Risk of Disease from Hazardous Waste: A Proposal for
Judicial Relief 60 WASH. L. Rv. 635, 635 (1985); Linda A. Elfenbein, Note, Future Medical
Surveillance: An Award for Toxic Tort Victims, 38 RuTGERS L. REV. 795, 795 (1986); Leslie
S. Gara, Note, Medical Surveillance Damages: Using Common Sense and the Common Law to
Mitigate the Dangers Posed by Environmental Hazards, 12 HARV. ENVTL. L. REV. 265, 266
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Toxic exposure victims often suffer immediate and direct physical
injuries as a result of the exposure.8 Besides immediate visible health
consequences, "environmental toxins tend to cause latent injuries-inju-
ries that are not fully apparent at the time of or immediately after expo-
sure." 9 The potential long-term health consequences include cancer,
dermatological injury, gastrointestinal disease, heart disease, respiratory
illnesses, and musculoskeletal disorders. 10 After exposure and prior to
the manifestation of exposure-related symptoms, individuals may be ad-
vised to undergo periodic medical testing for exposure-related health
problems." Legal commentators have urged legislators and courts to
recognize a claim for presymptom, postexposure medical monitoring
damages to provide individuals with the medical surveillance necessary
to detect the onset of exposure-related diseases.12 In fact, the American
Law Institute (ALl) recommended the recognition of a claim for medical
surveillance as one of four major environmental tort liability reform
measures in its two volume study, Enterprise Responsibility for Personal
Injury, released in April 1991.13
(1988); John K. McNamara, Jr., Note, Perfect Together: Ayers v. Jackson Township and
Presymptom Medical Surveillance Awards in Toxic Torts, 5 J. CONTEMP. HEALTH L. & PoL'Y
339, 341 (1989); Slagel, supra note 2, at 849-57, 876; Palma J. Strand, Note, The Inapplicability
of Traditional Tort Analysis to Environmental Risks: The Example of Toxic Waste Pollution
Victim Compensation, 35 STAN. L. REv. 575, 575 (1983); cf Ayers v. Jackson Township, 106
N.J. 557, 579, 525 A.2d 287, 298 (1987) (noting "the difficulty that both law and science
experience in attempting to deal with the emerging complexities of industrialized society and
the consequent implications for human health").
8. For example, in the days and weeks following a chemical explosion and fire at a wood
treatment plant in Oroville, California, residents reported suffering from "burning eyes, nose
and throat; skin rashes, hives, blisters and welts; severe sinus drainage and severe sinus head-
aches; nausea; cold sweats; and general malaise." Plaintiffs' Memorandum in Opposition to
Motion for Partial Dismissal of the Second Amended Complaint, at 3, Corron v. Koppers Co.,
No. CIVS 88-0433, (E.D. Cal. June 15, 1990). See also Villari v. Terminix Int'l, Inc., 663 F.
Supp. 727, 728 (E.D. Pa. 1987) (in the month after a pest control company employee spilled
Aldrin in their basement, the Villari family suffered headaches, nausea, dizziness and general
malaise).
9. 2 AMERICAN LAW INST., ENTERPRISE RESPONSIBILITY FOR PERSONAL INJURY 375
(1991).
10. 1 AMERICAN LAW INST., supra note 9, at 308; see also Ginsberg & Weiss, supra note
7, at 862 (mentioning various long-term mental and physical health effects as well as nonhealth
related consequences, such as loss of income and community impact).
11. The need for ongoing medical surveillance is often supported by expert medical testi-
mony. See, e.g., Ayers, 106 N.J. at 599 n.12, 525 A.2d at 309 n.12 (plaintiffs' expert testifying
that plaintiffs should undergo medical surveillance testing for a period ranging from one to
three years after exposure to establish baseline data; then commence regular medical surveil-
lance examinations at the onset of the risk of disease, estimated to be ten years after exposure;
and continue annually thereafter).
12. See, e.g., Ginsberg & Weiss, supra note 7; Trauberman, supra note 7; Elfenbein, supra
note 7; Gara, supra note 7; McNamara, supra note 7; Strand, supra note 7. The terms "medi-
cal surveillance" and "medical monitoring" will be used interchangeably in this Note.
13. 2 AMERICAN LAW INST., supra note 9, at 381-82. The ALI reporters made the fol-
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The individual and public health benefits of medical surveillance ap-
parently have motivated an increasing number of courts to permit toxic
exposure plaintiffs to pursue medical surveillance claims, 14 even when no
present injury exists.15 Despite this trend of recognizing medical moni-
lowing "interrelated and mutually dependent proposals": (1) the use of science panels and
court-appointed experts to assist courts with difficult causation issues; (2) the broad use of the
Comprehensive Environmental Response, Compensation, and Liability Act (CERCLA) defini-
tion of the "discovery rule" for tolling statutes of limitations; (3) the award of proportionate
compensation based on attributable fractions of disease; and (4) the award of medical monitor-
ing damages to fund appropriate surveillance and investigation of the path followed by the
disease within the exposed population. Id.
14. A claim for medical surveillance is one theory of presymptom recovery pursued in
toxic tort litigation. It must be distinguished from other toxic tort recovery theories such as
increased risk of cancer and fear of cancer, which courts are less likely to support. Larry J.
Ritchie, Claims for Fears in the 1990's (1989) (unpublished manuscript, on file with the Has-
tings Law Journal). The medical surveillance claim is designed to cover the cost of tests and
services to allow early detection of latent diseases resulting from exposure to toxic substances.
Id. In its April 1991 study the ALI declared that "treating medical surveillance costs as a
compensable harm is not equivalent to reimbursing individuals for their fear of cancer nor for
the pain and suffering associated with increased risk." 2 AMERICAN LAW INST., supra note 9,
at 380. While the ALI supports medical monitoring claims, it does not "advocate compensat-
ing individuals who are stricken with 'cancerphobia.'" Id.
Courts have held that a plaintiff need not suffer a present injury in order to sustain a
medical surveillance claim. Hagerty v. L & L Marine Servs., Inc., 788 F.2d 315, 319, modi-
fied, 797 F.2d 256 (5th Cir. 1986); Friends for All Children v. Lockheed Aircraft Corp., 746
F.2d 816, 827 (D.C. Cir. 1984). Courts also have held that the risk of contracting an exposure-
related disease need not be quantifiable in order to sustain a medical surveillance claim. See,
e.g., Ayers v. Jackson Township, 106 N.J. 557, 600, 525 A.2d 287, 309 (1987) (stating that
"medical science may necessarily and properly intervene where there is a significant but un-
quantifiable risk of serious disease"). In order to sustain a claim for increased risk of cancer,
however, courts will require the plaintiff to prove that the risk is not highly speculative. See,
eg., id. at 598, 525 A.2d at 308 (rejecting plaintiffs' increased risk claim because risk of acquir-
ing future diseases were unquantifiable). Fear of cancer claims are included in claims for emo-
tional distress and usually require a present physical injury as well as a serious and reasonable
fear of cancer. Ritchie, supra, at 12-14. In the absence of a present physical injury, however,
at least one court has permitted plaintiffs to recover for fear of cancer when the evidence
established that the fear was "genuine, serious and reasonable." Potter v. Firestone Tire &
Rubber Co., 232 Cal. App. 3d 1114, 1130, 274 Cal. Rptr. 885, 894 (1990), petition for review
granted, 806 P.2d 308, 278 Cal. Rptr. 836 (1991). For a thorough discussion of different toxic
tort theories, see Ritchie, supra; DORE, LAW OF Toxic TORTS, supra note 2, § 7.
15. The seminal case recognizing a claim for medical monitoring is Ayers, 106 N.J. 557,
525 A.2d 287 (discussed infra part II.C.). See infra note 87 for a list of cases recognizing
medical surveillance as an independent element of damages. Two federal courts sitting in
diversity have recently indicated the probability that the Colorado and Pennsylvania Supreme
Courts also will recognize a cause of action for medical monitoring. See In re Paoli R.R.
Litig., 916 F.2d 829, 852 (3rd Cir. 1990), cert. denied, 111 S. Ct. 1584 (1991); Cook v.
Rockwell Int'l Corp., 755 F. Supp. 1468, 1477 (D. Colo. 1991) (stating that "[c]ourts have
generally accepted tort claims for medical monitoring").
The courts in Merry v. Westinghouse Elec. Corp., 684 F. Supp. 847, 849 (M.D. Pa. 1988),
and Habitants Against Landfill Toxicants v. City of York, [1985] 15 Envtl. L. Rep. (Envtl. L.
Inst.) 20,937, 20,938 (Pa. Ct. C.P. May 20, 1985), required that a plaintiff seeking compensa-
tion for future medical surveillance demonstrate only the potential for physical injury, not
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toring claims, a handful of courts have refused to do so. 16 Other courts
make recovery for future medical surveillance difficult by requiring a
plaintiff to prove either a manifest injury or that, as a result of the expo-
sure, she has a reasonably probable or greater than average risk of devel-
oping a future disease.
17
In most of the cases recognizing medical monitoring claims, litigants
pursued or courts awarded the traditional common-law lump sum
18 of
monetary damages.19 A few courts that have recognized a claim for
medical surveillance expenses have adopted a more novel approach. Ac-
cording to these courts, the appropriate method of compensating toxic
exposure victims for future medical monitoring necessitated by defend-
physical injury itself. See also infra note 57 (citing cases in which no present physical injury
was required).
16. See, eg., Ball v. Joy Mfg. Co., 755 F. Supp. 1344, 1372 (S.D. W. Va. 1990), aff'd sub
nom. Ball v. Joy Technologies, Inc., No. 90-1537, 1991 U.S. App. LEXIS 17580 (4th Cir. Aug.
5, 1991) (recognizing the benefit of early diagnosis and treatment but refusing to recognize a
medical monitoring tort claim because allowing medical monitoring recovery "could poten-
tially devastate the court system as well as defendants"). See also Rheingold v. E.R. Squibb &
Sons, No. 74 CIV 3420 (S.D.N.Y. Oct. 8, 1975), and Morrissy v. Eli Lilly & Co., 76 111. App.
3d 753, 394 N.E.2d 1369 (1979), in which the plaintiffs requested the creation of medical
monitoring funds to provide medical treatment, as well as medical examinations. This point
has been used to distinguish Rheingold and Morrissy from cases in which plaintiffs pursue
"pure" medical monitoring claims, i.e., claims for diagnostic examinations and health studies
but not for treatment. See In re Paoli 916 F.2d at 851 n.25.
In her Note, Leslie Gara cites Rheingold and Morrissy, as well as the appeals court deci-
sion in Ayers, 202 N.J. Super. 106, 493 A.2d 1314 (1985), for the proposition that courts that
refuse to recognize medical monitoring claims fail to distinguish between a plaintiff seeking
compensation for a physical injury before the injury actually develops and a plaintiff requesting
damages for the injury of having been exposed to a toxic substance at a level necessitating
medical surveillance. Gara, supra note 7, at 285-86.
17. See, eg., Herber v. Johns-Manville Corp., 785 F.2d 79, 83 (3d Cir. 1986). In Potter
v. Firestone Tire & Rubber Co., 232 Cal. App. 3d 1114, 274 Cal. Rptr. 885 (1990), California's
Sixth District Court of Appeal reversed a $142,975 medical monitoring award based partly on
its conclusion that the court had no authority to uphold the award without proof that cancer
was "reasonably certain" to occur. Id. at 1126, 274 Cal. Rptr. at 891-92. Two couples alleged
that for seventeen years the defendant had improperly dumped toxic chemicals which leaked
into their wells. The case now is pending before the California Supreme Court.
18. The general rule for recovery of future damages is that they must be reduced to their
present worth and awarded in a single judgment. See Roger C. Henderson, Designing a Re-
sponsible Periodic-Payment System for Tort Awards: Arizona Enacts a Prototype, 32 ARiz. L.
Rav. 21, 25 (1990) (stating that under the common-law system of awarding lump sum dam-
ages, "[t]he trier of fact determines all damages at the time of trial, whether they be past,
present, or future"). In contrast, civil law systems previously have allowed payment of per-
sonal injury damages in periodic installments. Ia at 25 n.17.
19. See Hagerty v. L & L Marine Servs., Inc., 788 F.2d 315, modified, 797 F.2d 256 (5th
Cir. 1986); Herber, 785 F.2d 79; Merry, 684 F. Supp. 847; Villari v. Terminix Int'l, Inc., 663 F.
Supp. 727 (E.D. Pa. 1987); Johnson v. Armstrong Cork Co., 645 F. Supp. 764 (W.D. La.
1986); Ayers v. Jackson Township, 106 N.J. 557, 607, 525 A.2d 287, 314 (1987); Mauro v.
Owens-Coming Fiberglass, 225 N.J. Super. 196, 211-12, 542 A.2d 16, 17 (1988); Askey v.
Occidental Chem. Corp., 477 N.Y.S.2d 242, 102 A.D.2d 130 (App. Div. 1984).
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ants' tortious conduct is to pay the expenses on a periodic basis out of a
court-supervised trust fund or similar mechanism.
20
The use of such an ongoing fund mechanism constitutes the periodic
payment of damages awards-a method of paying damages that has
gained popularity since the mid-1970s, particularly in the settlement con-
text.21 Legislation in many states mandates periodic payments in specific
types of lawsuits. For instance, many workers' compensation, medical
malpractice, family support, and auto liability statutes mandate periodic
payments. 22 These statutes guide courts in implementing periodic pay-
ment plans in a variety of circumstances, but courts that have approved
periodic payment of future medical surveillance expenses in toxic tort
cases have, perforce, done so in the absence of'legislative guidance.
23
Consequently, these courts have relied on their equitable powers to fash-
ion appropriate remedies.24
20. In Ayers, the New Jersey Supreme Court recommended that trial courts appoint ad-
ministrators to manage medical surveillance funds. While declining to upset the jury award of
a lump sum, the New Jersey Supreme Court expressly stated that a court-supervised fund was
the preferred method of compensating toxic tort victims for the cost of medical monitoring.
Ayers, 106 N.J. at 610 & n.14, 525 A.2d at 314 & n.14. For other toxic exposure cases in
which courts either expressly preferred medical monitoring funds over lump sum payments or
permitted plaintiffs to pursue a fund remedy, see Barth v. Firestone Tire & Rubber Co., 673 F.
Supp. 1466, 1476 (N.D. Cal. 1987); Burns v. Jaquays, 156 Ariz. 375, 381, 752 P.2d 28, 34 (Ct.
App. 1988); Habitants Against Landfill Toxicants v. City of York, [1985] 15 Envtl. L. Rep.
(Envtl. L. Inst.) 20,937 (Pa. Ct. C.P. May 20, 1985). In Friends for All Children v. Lockheed
Aircraft Corp., 746 F.2d 816 (D.C. Cir. 1984), a case involving a plane crash and not toxic
exposure, the court affirmed the appropriateness of the trust fund mechanism over a lump sum
award for medical surveillance. Id. at 835-36.
21. See JAMES ECK & JEFFREY UNGERER, STRUCTURING SETTLEMENTS 1 (1987).
While the authors specifically examine periodic payment settlements to assist practitioners in
designing and implementing structured settlement plans, much of the information is equally
applicable to periodic payment judgments.
22. See Tom Elligett, The Periodic Payment of Judgments, 46 INs. COUNS. J. 130, 133
(1979) (stating that judgment debtors of modest means often are required to pay alimony peri-
odically); id. at 134, nn.46-48 (discussing periodic payment provisions in no-fault automobile
statutes); id. at 133 n.36 (discussing workers' compensation statutes); id at 134 n.49 (noting
medical malpractice actions); Henderson, supra note 18, at 27-28 (surveying the periodic pay-
ment statutes of over thirty states, most of which pertain only to medical malpractice actions);
see also Michaela M. White, Strange Bedfellows: The Uneasy Alliance Between Bankruptcy
and Family Law, 17 N.M. L. REv. 1, 31-32 (1987) (distinguishing between lump sum family
support payments and family support payments paid periodically, and discussing the effect the
form of payment has for bankruptcy law purposes).
23. One court has stated that "[w]ithout a comprehensive governmental response to the
problem of compensating victims of toxic exposure, the only available remedy lies within the
legal system." Ayers, 106 N.J. at 581, 525 A.2d at 299. Congress has recognized the need for
ongoing medical surveillance in some circumstances. See The Occupational Safety and Health
Act, 29 U.S.C. § 655(b)(7) (1988) (requiring employers to provide medical surveillance to
"employees exposed to such hazards in order to most effectively determine whether the health
of such employees is adversely affected by such exposure").
24. See Barth, 673 F. Supp. at 1476-78 (denying defendant's motion to dismiss plaintiff's
medical monitoring claim on the ground that a claim lies in equity prior to the development of
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This Note accepts the premise that future medical surveillance ex-
penses should be compensated and examines the feasibility of using peri-
odic payment plans such as structured settlements or court-supervised,
defendant-funded monitoring funds to compensate plaintiffs for pos-
texposure, presymptom medical surveillance. Part I examines the devel-
opment and recognition of the medical surveillance claim. The legal,
practical, and public policy reasons supporting medical surveillance
claims in toxic tort litigation are outlined to provide the reader with an
understanding of the complex challenges toxic exposure victims face
when they seek compensation for future medical surveillance. Part II
examines the cases and legislation that have established periodic pay-
ments as an alternative to the traditional lump sum damages award in
tort litigation. This Part also highlights the practical advantages and dis-
advantages of periodic payments, as well as the ethical and constitutional
considerations involved. Part III examines the nexus between periodic
payments and the claim for medical surveillance, including the reasons
why the periodic payment of medical surveillance expenses may be more
appropriate than awarding lump sum awards. This Part traces the out-
come of previous efforts to establish court-supervised medical surveil-
lance funds, foundations, or similar mechanisms, with special emphasis
on the successful Fernald litigation settlement.2 5 Finally, in Part IV the
author proposes a variety of considerations to guide practitioners in im-
plementing and administering successful periodic payment plans for
medical monitoring.
I. The Claim for Medical Surveillance
A. Traditional Tort Analysis Inadequately Addresses the Unique
Characteristics of Toxic Tort Litigation
26
In its April 1991 tort reform study the ALI reported that, despite
conservative estimates of approximately 10,000 environmentally related
diagnosable symptoms); Ayers, 106 N.J. at 608-09, 525 A.2d at 314 (stating that "the use of a
court-supervised fund to administer medical-surveillance payments... is a highly appropriate
exercise of the Court's equitable powers"); see also 30A C.J.S. Equity § 599 (1965) (stating that
"the court has a broad discretion in framing its decrees in order to adapt the relief to the
circumstances of particular cases").
25. Judge S. Arthur Spiegel's Opinion and Order Approving Settlement and Denying
Objections sets out the history of the litigation and the settlement terms. In re Fernald Litig.,
No. C-1-85-0149 (S.D. Ohio Sept. 29, 1989).
26. See, e.g., Gara, supra note 7, at 303 (concluding that "one of the failures of the tort
system thus far has been the great obstacles placed between the victim of hazardous substance
exposure and her ability to obtain compensation through the courts for the costs of required
medical testing and monitoring").
In Barth, the court observed that:
[C]urrent medical science cannot state whether or how exposure to toxic chemicals
affects individuals. It cannot yet detect the present effect of the exposure, and,
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cancer deaths per year, there has been comparatively little litigation al-
leging personal injury as a result of exposure to hazardous substances.
27
Between 1983 and 1986, for example, less than fifty million dollars was
awarded to plaintiffs in environmental tort cases to reimburse them for
the costs of personal injuries. 28 In sharp contrast, approximately 4.8 bil-
lion dollars was paid to reimburse medical malpractice plaintiffs for per-
sonal injuries. 29 This suggests that the number of toxic exposure cases in
which plaintiffs sought compensation for ongoing medical monitoring,
either exclusively or as a component of a larger personal injury award, is
small. Legal commentators attribute this to the fact that traditional tort
analysis inadequately addresses the unique characteristics of toxic tort
litigation; the result is that severe technical, legal, and economic obsta-
cles deter toxic tort victims from initiating litigation by making it difficult
for toxic tort plaintiffs to win a reasonable recovery.
30
The common law tort system was developed to address conflicts
raised by simple, straightforward traumatic injuries.31 Ordinary tort
cases, such as automobile accidents, usually involve injuries that can be
detected immediately, such as bruises and broken bones. Toxic tort inju-
ries, however, may remain undetected for years because cancer and other
exposure-related diseases have long latency periods, during which time
the ailment cannot be clinically diagnosed.32 Because of the long latency
periods, toxic exposure victims may fail to initiate an action because they
do not know that they have been harmed by a toxic substance.
therefore, it cannot supply to the legal system information concerning the nature of
present injury or of causation. In the absence of that information, the legal system
now struggles to adapt.
Barth, 673 F. Supp. at 1469.
27. 2 AMERICAN LAW INST., supra note 9, at 355 (citing Richard Doll & Richard Peto,
The Causes of Cancer: Quantitative Estimates ofAvoidable Risks of Cancer in the United States
Today, 66 J. NAT'L CANCER INST. 1191 (1981)).
28. Id at 355-56.
29. Id at 356.
30. See generally 2 AMERICAN LAW INT., supra note 9, ch. 11 (discussing problems
posed by latency periods, abridged evidence of exposure, and probabilistic evidence of causa-
tion). See also Ginsberg & Weiss, supra note 7, at 924-28; Trauberman, supra note 7, at 189-
91; Strand, supra note 7, at 584-86. These commentators discuss various inadequacies of tradi-
tional tort analysis such as the difficulty environmental plaintiffs confront in identifying parties
responsible for environmental damage, the risk that such parties are judgment-proof, the ex-
pense of retaining expert witnesses in specialized fields such as toxicology and epidemiology,
and the cost and complexity of protracted multi-party litigation.
31. Slagel, supra note 2, at 851 (citing Strand, supra note 7, at 576-77).
32. Id. at 852 n.15. The latency period is the time between exposure and the appearance
of symptoms. Michael Dore, A Commentary on the Use of Epidemiological Evidence in Dem-
onstrating Cause-In-Fact, 7 HARv. ENVTL. L. REv. 429, 429 n.2 (1983) [hereinafter Dore,
Epidemiological Evidence in Demonstrating Cause-In-Fact]. Latency periods of 1 to 50 years
have been cited by commentators. Id.
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Two procedural obstacles that stem from the long latency periods of
exposure-related illnesses may hinder recovery in toxic exposure cases.
First, the exposure-related illness may not be discovered until long after
the applicable statute of limitations has run, thus barring the plaintiff
from recovery. In its 1986 amendments to the Comprehensive Environ-
mental Response, Compensation, and Liability Act of 1980, (CERCLA
or Superfund),33 Congress enacted a mandatory federal commencement
date defined as "the date the plaintiff knew (or reasonably should have
known) that the personal injury... [was] caused or contributed to by the
hazardous substance... concerned."' 34 The ALI recently proposed that
all jurisdictions apply the same "discovery rule" in legal settings in which
the federal statute does not apply. 35 Most jurisdictions have already
adopted a version of the discovery rule that tolls the statute until the
injury is discovered or should have been discovered.
36
The second procedural obstacle is the single controversy rule.37 The
application of this rule may bar recovery for future harm when the initial
suit seeks only compensation for the immediate consequences of the toxic
exposure. If an exposed individual discovers physical injury after the ini-
tial litigation concludes, the rule operates to bar the individual from seek-
ing compensation for physical injuries discovered after the first
resolution. 38 In recognizing this result as unjust, a few courts have deter-
mined that "neither the statute of limitations nor the single controversy
rule should bar timely causes of action in toxic-tort cases instituted after
discovery of a disease or injury related to tortious conduct."' 39 The trend
among the states has been to create doctrines, generically called "second
33. 42 U.S.C. §§ 9601-9675 (1988).
34. Id §§ 9658(a)(1), 9658(b)(4)(A); see also Sheila L. Birnbaum, Statutes of Limitations
in Environmental Suits: The Discovery Rule Approach, TRIAL, Apr. 1980, at 38.
35. 2 AMERICAN LAW INST., supra note 9, at 364, 381. The term "discovery rule" gen-
erally refers to the rule that a cause of action will not accrue until the plaintiff knows, or with
reasonable diligence, should have known of the alleged tort. The term is most often applied in
the medical malpractice context but has been used in others as well. See BLACK'S LAW DIC-
TIONARY 419 (5th ed. 1979).
36. Trauberman, supra note 7, at 191 & n.65. An example of a liberal discovery rule is
the New Jersey statute, which tolls the statute until the victim has discovered both the injury
and the facts suggesting that a third party might be responsible. Ayers v. Jackson Township,
106 N.J. 557, 583, 525 A.2d 287, 300 (1987).
37. The single controversy rule, also referred to as the single recovery rule, is the tort
doctrine which requires that a party include in a single action all related claims against an
adversary. DANIEL W. HINDERT ET AL., STRUCTURED SETTLEMENTS AND PERIODIC PAY-
MENT JUDGMENTS § 1, at 1-6 to 1-7 (1986 & Supp. 1988).
38. Ayers, 106 N.J. at 583, 525 A.2d at 300.
39. Id. at 584, 525 A.2d at 300; see also Hagerty v. L & L Marine Servs., Inc., 788 F.2d
315, 320-21, modified, 797 F.2d 256 (5th Cir. 1986) ("At least in the toxic chemical or asbestos
cases, the [subsequent exposure-related disease] should be treated as a separate cause of action
for all purposes. There should be no cause of action or beginning of the running of limitations
until the diagnosis of the disease.").
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injury rules," which, under certain circumstances, allow a new statute of
limitations period to start running for subsequently manifested injuries.40
A court in New York recently adopted the second-injury rule for asbes-
tos cases.
41
In addition to these two procedural barriers, toxic tort victims must
overcome a host of practical obstacles. Those individuals who are aware
of their exposure to hazardous substances may be unable to identify the
parties against whom claims may be pursued. By the time an exposure-
related harm manifests itself, parties that engaged in toxic dumping and
other hazardous endeavors may be out of business and, therefore, out of
reach of the courts.42 The covert, illicit practices of unscrupulous pol-
luters also may prevent exposure victims from identifying potential
defendants.43
40. Paul D. Rheingold & Richard S. McGowan, Statutes of Limitations in New York
Toxic Tort Cases, N.Y. L.J., July 13, 1990, at 1 (discussing New York's adoption of a second
injury rule for toxic exposure cases). As cited by Rheingold and McGowan, supra, at 1 n.1,
the following decisions illustrate the variety of second injury rules in other states: Jackson v.
Johns-Manville Sales Corp., 727 F.2d 506 (5th Cir. 1984), cert. denied, 478 U.S. 1022 (1986);
Wilson v. Johns-Manville Sales Corp., 684 F.2d 111 (D.C. Cir. 1982); Fearson v. Johns-
Manville Sales Corp., 525 F. Supp. 671 (D.D.C. 1981); Sheppard v. A.C.&S. Co., 498 A.2d
1126 (Del. Super. 1985), afld, 503 A.2d 192 (1986); Eagle-Picher Indus., Inc. v. Cox, 481 So.
2d 517 (Fla. Dist. Ct. App. 1985); Smith v. Bethlehem Steel Corp., 303 Md. 213, 492 A.2d
1286 (1985); Pierce v. Johns-Manville Sales Corp., 296 Md. 656, 464 A.2d 1020 (Ct. App.
1983); Larson v. Johns-Manville Sales Corp., 427 Mich. 301, 399 N.W.2d 1 (1986); Devlin v.
Johns-Manville Sales Corp., 202 N.J. Super. 556 (1985); see also Goodman v. Mead Johnson &
Co., 534 F.2d 566 (3d Cir. 1976); Martinez-Ferrer v. Richardson-Merrell, Inc., 105 Cal. App.
3d 316, 164 Cal. Rptr. 591 (1980).
41. In Fusaro v. Porter-Hayden Co., 145 Misc. 2d 911, 548 N.Y.S.2d 856 (Sup. Ct.
1989), the court permitted the plaintiff employee to seek compensation for mesothelioma (a
cancer), which the employee had just recently developed, even though the same employee
previously had sued the defendant asbestos suppliers for asbestosis. Id at 918, 548 N.Y.S.2d
at 860. The court accepted the plaintiff's proof that the cancer and his earlier condition of
asbestosis involved different disease processes in the body. Id at 915, 548 N.Y.S.2d at 859.
The decision is on appeal. Rheingold & McGowan, supra note 40, at 4.
42. Ginsberg & Weiss, supra note 7, at 927.
43. Id. at 925. The conduct of Monsanto, a producer of Agent Orange, illustrates the
"covert, illicit practices" cited by Ginsberg and Weiss. In the course of litigating workers'
claims for occupational exposure to dioxin, several memoranda surfaced that revealed Mon-
santo's refusal to fully and honestly respond to employee requests for chemical-exposure and
occupational-disease data. In a November 1977 memorandum Monsanto directed its plant
managers to "resist" employee and union requests for the data. John Riley, A Silver Bullet-
Or Merely a Dud?: Lawyers Take Aim at Dioxin, NAT'L L.J., July 23, 1984, at 1. The memo-
randum instructed operating personnel to issue evasive responses to employee questions and to
refer employee inquiries to St. Louis where "as limited a response as deemed appropriate will
be developed." Id.
The secret investigation by Alyeska Pipeline Service Company is a more recent example
of the illicit practices of polluters. In the face of international criticism stemming from lapses
in Alyeska's environmental and safety programs, the company launched an aggressive cam-
paign to silence critics and avoid embarrassing disclosures. Alyeska hired the Wackenhut Cor-
poration, the nation's third largest private security company, to launch a secret investigation of
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The sheer expense of toxic tort litigation serves as a practical barrier
for many toxic exposure victims. Individuals confronted with hazardous
substances in their homes or at work are often of limited or modest finan-
cial means.44 Individuals who reside near industrial areas where hazard-
ous substances are used or produced, and those who reside near toxic
waste dumps, are usually ill-equipped financially to pursue their claims
against well financed corporate or government defendants.45 As a result
of these practical problems, toxic exposure victims may settle earlier and
for less money than other plaintiffs.
The burden of proving legal causation is perhaps the most difficult
obstacle confronting toxic exposure plaintiffs.4 6 Four potential causes of
Charles Hamel, a former oil broker who was battling several oil companies in court. Alyeska
believed that Mr. Hamel had become a conduit for leaked documents that incriminated the
company. Alyeska was infuriated after incriminating documents turned up in the hands of
regulators and the news media. During the course of the illicit investigation, Wackenhut
agents bought sophisticated eavesdropping equipment and set up a sting operation. The agents
used phony credentials from a fake environmental group to gain entry to Mr. Hamel's home,
where they stole documents from his desk. See Keith Schneider, A Case of Heavy-Footed
Gumshoes, N.Y. TIMES, Nov. 10, 1991, at E3.
Even as the author was researching and writing this Note, reports surfaced in the media
that Dow Coming, the manufacturer of silicone breast implants, may have disregarded its own
safety inspectors' memoranda outlining concerns about the long-term health effects of the
breast implants, and withheld safety information from government regulators and consumers.
See, e.g., Tamar Lewin, As Silicone Issue Grows, Women Take Agony and Anger to Court, N.Y.
TIMES, Jan. 19, 1992, § 1, at 1, 13 (stating that a major portion of a San Francisco jury's $7.2
million damage award represented punitive damages against Dow Coming for fraud and mis-
representation of its safety studies).
44. According to one survey of the Los Angeles basin, a majority of the city's economi-
cally disadvantaged population live in the most polluted areas. Home Street, USA: Living
With Pollution, GREENPEACE, Oct./Nov./Dec. 1991, at 8, 10. This same group also is dispro-
portionately employed in the state's polluting industries. Id.
In Chicago the Altgeld Gardens housing project is called "the toxic donut" because it is
surrounded by landfills, incinerators and factories. Id. at 13. The 150,000 residents of Chi-
cago's southeast side live with 50 active or closed commercial hazardous waste landfills, 100
factories (including seven chemical plants and five steel mills), and 102 abandoned toxic waste
dumps. Id.
45. See Ginsberg & Weiss, supra note 7, at 924 (stating that, "for plaintiffs who cannot
pay for medical treatment or alternative housing, a legal remedy permeated with uncertainty
and delay may be equivalent to no remedy at all, and the lure of a prompt settlement, however
inadequate, may be irresistible") (emphasis in original).
46. For a complete discussion of proof of causation problems in toxic tort litigation see 2
AMERICAN LAW INST., supra note 9, ch. 11 (discussing the scientific and legal causation
problems posed by environmental torts, and offering solutions); Rosenberg, supra note 7, at
855-60 (illustrating how traditional causation standards make it impossible for plaintiffs to
prove causation in mass exposure cases, and offering a "public law" alternative); see also Gins-
berg & Weiss, supra note 7, at 922-24 (discussing difficulty of proving both that a particular
toxin caused an illness and that defendant was the source of that toxin as opposed to other
potential sources); Trauberman, supra note 7, at 197-201 (same); Stephen M. Soble, Statute, A
Proposal for the Administrative Compensation of Victims of Toxic Substance Pollution: A
ModelAct, 14 HARV. J. LEGIS. 683, 706 (1977) (discussing extensive scientific data required to
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action are available to plaintiffs litigating environmental torts: trespass,
nuisance, strict liability, and negligence.47 Early environmental tort law
was based on the trespass and nuisance doctrines and was aimed primar-
ily at protecting the property rights of private individuals.48 In the late
1950s and early 1960s courts began to apply these traditional doctrines to
environmental claims; industrial emissions such as chemical dusts and
fumes were declared trespasses when they caused damage to neighboring
property, and nuisance claims were permitted when no physical entry
existed.
More recently, environmental tort plaintiffs seeking redress for per-
sonal injury have relied on both strict liability and negligence theories.
Some environmental tort plaintiffs have attempted to recover under a
strict liability theory by arguing that their injuries resulted from defend-
ants' "ultrahazardous" activities.49 However, most environmental tort
plaintiffs rely on a negligence theory for recovery, requiring them to
show by a preponderance of the evidence that the defendant's behavior
was a substantial factor in causing their injuries.50 Scientific uncertainty
about cancer and other exposure-related diseases with long latency peri-
ods exacerbates a toxic tort claimant's ability to establish such a cause-in-
fact or substantial relationship between her injury and her exposure to a
particular toxic substance.5
1
show causation and noting that even full-scale studies do not guarantee success in proving
causation); Gara, supra note 7, at 274 (latency period between exposure to toxin and develop-
ment of disease is often lengthy, making it difficult to prove that a certain toxin at issue in a
toxic tort case, as opposed to some other toxin, actually caused the plaintiff's injury); McNa-
mara, supra note 7, at 342-43 (same); Slagel, supra note 2, at 853-54 (physiological mecha-
nisms of diseases caused by toxic torts are often not well understood, making it difficult for
plaintiff to establish cause-in-fact). These commentators highlight the difficulties that arise in
proving causation in toxic tort cases. See also Joseph Sanders, The Bendectin Litigation: A
Case Study in the Life Cycle of Mass Torts, 43 HASTINGS L.J. 301 (1992) (detailed analysis of
the evolving legal treatment of causation in the litigation surrounding the drug Bendectin.
While the Bendectin litigation was based on products liability law rather than toxic tort law,
similar causation issues are involved.).
47. See Ginsberg & Weiss, supra note 7, at 880-913.
48. See 1 AMERICAN LAW INST., supra note 9, at 309-10. Trespass prohibits unauthor-
ized entry or physical invasion upon another's land, while nuisance prohibits the interference
with a person's use or enjoyment of her property. Id
49. Strict liability for "ultrahazardous" activity may be invoked only when an activity is
considered "abnormally dangerous." 2 AMERICAN LAW INST., supra note 9, at 365 (citing
RESTATEMENT (SECOND) OF TORTS § 520 (1977)).
50. Trauberman, supra note 7, at 197.
51. Dore, Epidemiological Evidence in Demonstrating Cause-In-Fact, supra note 32, at
429; Rosenberg, supra note 7, at 855-56; Trauberman, supra note 7, at 198-99; William V.
Dunlap & E. Michael Paul Thomas, Note, Tort Actions for Cancer: Deterrence, Compensation
and Environmental Carcinogens, 90 YALE L.J. 840, 853-55 (1981).
The ALI cites four types of uncertainty that one might encounter in proving hazardous
substance causation: (I) trans-scientific uncertainty (arises when scientific issues are not ame-
nable to scientific proof); (2) confidence interval uncertainty (results from gaps in statistical
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Litigants must employ expert witnesses in toxicology, epidemiology,
and related disciplines to prove that the claimed health disorders either
were or were not caused by the claimants' exposure to specific toxic sub-
stances. The experts may present evidence to prove causation in a vari-
ety of forms such as cluster analysis, short-term molecular assays, animal
bioassays, and epidemiological studies.52 Various courts have stressed
their preference for epidemiological studies.5 3 Commentators have cau-
tioned that public health agencies and others who gather and use epide-
miological data can manipulate it to avoid finding health problems that
may have resulted from exposure.5 4 Because the toxic tort plaintiff's bur-
analyses and, therefore, casts doubt on some scientific studies); (3) multiple causation uncer-
tainty (arises because a single injury or disability such as cancer may have many potential
causes, e.g., toxic exposure, smoking habits, or diet); and (4) individual attribution uncertainty
(a subset of multiple causation uncertainty that arises because statistics give information about
groups of individuals generally and, therefore, fail to take an individual's own behavior into
account when determining whether the defendant alone caused the plaintiff's injury). 2 AMER-
ICAN LAW INST., supra note 9, at 324-28.
52. 2 AMERICAN LAW INST., supra note 9, at 321-24. Cluster analysis involves the re-
view of "clusters" of cases involving rare disease and the search for some common exposure as
a potential cause. lId at 321. Short-term molecular assays "take advantage of the similarities
between the metabolic processes of humans and other forms of life to develop experiments that
are relatively inexpensive and quick to complete." Id at 323. Animal bioassays are more
expensive and difficult to complete. "In an animal bioassay experiment scientists give several
hundred mammals prescribed doses of a particular toxic substance and then identify causes of
death in the animal cohort." Id "Epidemiology is the application of statistical techniques to
the study of disease in groups of individuals." Id. at 324. Epidemiologists do not conduct
experiments; rather, they look for statistical correlations between exposures and disease out-
comes. Id.
53. Sabrina Strawn & Marvin S. Legator, Epidemiology and Toxic Torts: Animal Studies
Yield ValidInsights, TRIAL, Apr. 1991, at 60, 61. The judge in the Agent Orange litigation, in
expressing his preference for epidemiological studies, discounted animal studies and informa-
tion from industrial accidents, stating that they lacked probative force and were potentially
misleading. Id. (citing In re Agent Orange Prod. Liab. Litig., 611 F. Supp. 1223, 1241
(E.D.N.Y. 1985)). In the Bendectin litigation, one judge determined that animal bioassays "do
not have the capability of proving causation in human beings in the absence of any confirma-
tory epidemiological data." Id, (citing Lynch v. Merrell-Nat'l Labs, 830 F.2d 1190, 1194 (1st
Cir. 1987)).
Whether it is possible for scientists to identify the adverse health consequences in a com-
munity resulting from exposure to toxic chemicals was a question addressed at a 1989 confer-
ence sponsored by the Centers for Disease Control, the Agency for Toxic Substances and
Disease Registry, and the Association of State and Territorial Health Officials. See AM. J.
EPIDEMIOLOGY, Supp. 1 (July 1990), for a compilation of many of the papers presented at the
conference.
54. Strawn & Legator, supra note 53, at 62. For instance, the Center for Disease Control
has been criticized for compromising its epidemiological study of Agent Orange as a result of
political pressures. Id. In their July 30, 1990 memorandum in response to Rockwell's motion
to dismiss, the plaintiffs in Cook v. Rockwell Intl Corp. questioned the validity of major radia-
tion studies of populations surrounding nuclear facilities and of nuclear facility workers that
were conducted by the Department of Energy (DOE). According to the plaintiffs, "[t]he qual-
ity of [the DOE studies] has varied, and some studies have been outright embarrassments,
drawing charges of compromised scientific integrity." Plaintiffs' Memorandum in Response to
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den of proving causation is often insurmountable, commentators have
proposed alternatives, including the application of modified principles of
causation, which they believe would lessen the burden. 5
Besides the difficulties that confront environmental tort plaintiffs in
general, those who seek recovery for future medical surveillance face ad-
ditional challenges. For example, traditional tort doctrine requires that a
plaintiff prove the existence of a present injury in order to recover dam-
ages for that injury. Courts have denied medical surveillance claims be-
cause at the time of litigation the claimant lacks visible physical injuries
on which to base a damage award.56 Other courts have dispensed with
Defendant's Motion to Dismiss at 20, Cook v. Rockwell Int'l Corp., 755 F. Supp. 1468 (D.
Colo. 1991) (No. 90-B-181).
To relieve "battles of the experts" and to ensure impartiality, the ALI recommends the
creation of a Federal Science Board that would assist common law courts in presenting and
assessing scientific evidence. See 2 AMERICAN LAW INsT., supra note 9, at 335-39. The Sci-
ence Board would maintain a list of approved experts from which courts could select court-
appointed experts. The Science Board would also create impartial "blue ribbon" science
panels such as the Food and Drug Administration's Public Board of Inquiry to research and
decide whether a causal link was present between a particular substance and a disease process.
Id.
55. See, e.g., Ginsberg & Weiss, supra note 7, at 938 (proposing the use of a presumption
of causation "if the claimant makes a prima facie showing that exposure to a toxic waste could
have been a substantial factor in the causation of an injury or disease"); Soble, supra note 46, at
709-14, 742-48 (advocating modified causation requirements based on a Japanese model);
Strawn & Legator, supra note 53, at 63 (proposing the acceptance of animal data as a surrogate
for assessing the cause of exposure-related diseases in humans); Trauberman, supra note 7, at
263-65 (commenting that a toxic exposure victim should benefit from a rebuttable presumption
of causation absent a showing that she "knowingly and voluntarily encountered" the risk).
Trauberman discusses three methods of modifying proof of causation requirements. The
first method is to use sliding-scale burdens of proof that vary according to the risks and bene-
fits of the activity allegedly responsible for the harm. The second method is to assess the risk
of harm to a group of persons exposed to a chemical and provide fractional recoveries to the
entire group. Trauberman rejects the first two approaches and, instead, advocates the adop-
tion of the third approach, which utilizes a system of rebuttable presumptions. Trauberman,
supra note 7, at 225-30. Soble proposes similar modifications of causation requirements. See
Soble supra note 46, at 743-47.
The ALI proposes a different causation modification. Under the ALI proposal, if the
state of scientific knowledge at the time of the environmentally risky activity gave no signal
that the activity posed a substantial risk to human health, then strict liability could not be
imposed. However, strict liability could be imposed regardless of the state of knowledge if the
defendant failed to employ available technology that could have eliminated or reduced the risk
in question. 2 AMERICAN LAW INST., supra note 9, at 368. According to the ALI, this
method would deter defendants from failing to apply available safety precautions, while reduc-
ing what some commentators refer to as the "overdeterrence" stemming from the threat of
absolute strict liability. Id.
For a general discussion of how courts can best guide litigants in their use of epidemiolog-
ical data, see Dore, supra note 32 (concluding that courts can solve the problems inherent in
the use of epidemiological data by instituting stringent and consistent controls on such use).
56. See Potter v. Firestone Tire & Rubber Co., 225 Cal. App. 3d 213, 232, 274 Cal. Rptr.
885, 896 (1990), petition for review granted, 806 P.2d 308, 278 Cal. Rptr. 836 (1991). The trial
court had awarded the plaintiffs the cost of periodic medical monitoring. In rejecting the trial
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the present-injury requirement in recognizing claims for future medical
surveillance.57 Commentators note that courts could resolve the present-
injury dilemma by recognizing that an individual who is forced to un-
dergo medical testing as a result of a defendant's conduct has suffered a
present, compensable injury, i.e., exposure to a level necessitating medi-
cal surveillance.58 These and other difficulties faced by a toxic tort claim-
ant support the need for the legal system to depart from traditional tort
analysis and to recognize a claim for postexposure, presymptom medical
surveillance.
B. Legislative Responses Fail to Adequately Address Medical Surveillance
Needs
CERCLA59 and the Resource Conservation and Recovery Act
(RCRA)6° constitute the primary legislation dealing with hazardous
waste and other toxic substances. This legislation, which is directed to-
ward regulation of hazardous waste and disposal, provides no adequate
remedy for compensating toxic exposure victims for personal injuries. 61
RCRA's stated purpose was to monitor hazardous wastes from "cradle-
to-grave," while CERCLA was designed as a "comprehensive" package
aimed at "removing-or at least containing-the hazardous remnants of
past practices. '62 Although it is generally recognized that CERCLA
provides no private remedy for personal injury,63 federal district courts
court's award, the appellate court declined to dispense with the physical-injury requirement,
even though it recognized that "some courts have circumvented the problem of an absence of
physical injury by simply holding that no physical injury is required." Id.
57. Toxic tort cases in which courts required no present physical injury include In re
Paoli R.R. Litig., 916 F.2d 829, 852 (3d Cir. 1990), cert denied, 111 S. Ct. 1584 (1991); Merry
v. Westinghouse Elec. Corp., 684 F. Supp. 847, 849 (M.D. Pa. 1988); Burns v. Jaquays Mining
Corp., 156 Ariz. 375, 380, 752 P.2d 28, 33 (Ct. App. 1987); Ayers v. Jackson Township, 106
N.J. 557, 606, 525 A.2d 287, 312 (1987); Askey v. Occidental Chem. Corp., 477 N.Y.S.2d 242,
247, 102 A.D.2d 130, 135 (App. Div. 1984).
58. See generally Ginsberg & Weiss, supra note 7, at 930 (advocating recognition of a
medical surveillance claim based on the view that having to undergo medical testing is, in
itself, a present, compensable injury, but arguing that compensation should be through the use
of an administrative fund, rather than a judicial remedy); Soble, supra note 46 (same);
Trauberman, supra note 7 (same); Gara, supra note 7 (advocating recognition of a medical
surveillance claim in toxic tort litigation); Slagel, supra note 2 (same).
59. Comprehensive Environmental Response, Compensation, and Liability Act of 1980,
42 U.S.C. §§ 9601-9675 (1988).
60. 42 U.S.C. §§ 6901-6987 (1988).
61. See SUPERFUND SECTION 301(E) STUDY GROUP FOR THE SENATE COMM. ON ENV'T
AND PUB. WORKS, 97TH CONG., 2D SESS., INJURIES AND DAMAGES FROM HAZARDOUS
WASTES-ANALYSIS AND IMPROVEMENT OF LEGAL REMEDIES (Comm. Print 1982) (dis-
cussing problems such as statutes of limitation, apportionment of liability among defendants,
and proof of causation that hinder compensation of hazardous waste victims).
62. McNamara, supra note 7, at 340 (quoting 40 C.F.R. § 260 (1980), and Ayers v. Jack-
son Township, 106 N.J. 557, 580, 525 A.2d 287, 298 (1987)).
63. Id.
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are divided over the issue of whether medical monitoring costs can be
recovered as a "necessary cost of response" under CERCLA.
64
Courts that have recognized medical monitoring claims under CER-
CLA have found that medical testing expenses incurred to assess the ef-
fect of the toxic exposure on the public, versus on an individual's health,
are recoverable response costs. 65 In denying a motion to dismiss a claim
for medical monitoring under CERCLA, the court in Brewer v. Ravan
stated, "[T]o the extent that plaintiffs seek to recover the cost of medical
testing and screening conducted to assess the effect of the release or dis-
charge on public health or to identify potential public health problems
presented by the release, ... they present a cognizable claim under [CER-
CLA]. 66 Evidently, the Brewer court distinguished medical expenses in-
curred to treat personal injuries from those medical expenses incurred to
assess the effect of the release or discharge on the public health. Accord-
ing to the Brewer court, the former did not qualify as "necessary costs of
response" under CERCLA, but the latter did.
67
Despite the Brewer line of cases, the trend among the federal courts
appears to be to reject recognition of a medical monitoring claim under
CERCLA. For instance, in Ambrogi v. Gould, Inc.68 the court deter-
mined that, "[a]fter reviewing the language of CERCLA, the legislative
history and the case law, we believe that costs of medical screening and/
or future medical monitoring are clearly not 'necessary costs of response'
under [CERCLA]. ' 69 The court in Keister v. Vertac Chemical Corp.7
0
held that medical monitoring costs are not recoverable under CERCLA
because they do not qualify as costs of "removal" or "remedial" action.71
64. See Medical Monitoring Costs, 59 U.S.L.W. 2543 (Mar. 12, 1991).
65. See, eg., Williams v. Allied Automotive, Autolite Div., 704 F. Supp. 782, 784 (N.D.
Ohio 1988); Brewer v. Ravan, 680 F. Supp. 1176, 1179-80 (M.D. Tenn. 1988).
66. 680 F. Supp. at 1179 (emphasis in original).
67. Id. In reaching its conclusion, the Brewer court cited an earlier decision, Jones v.
Inmont Corp., 584 F. Supp. 1425, 1429-30 (S.D. Ohio 1984), in which the court made a similar
distinction between medical services to treat personal injuries and medical screening to assess
the public health effects of a particular discharge or release. Id.
Other cases in which district courts have recognized medical monitoring as response costs>
under CERCLA include Cook v. Rockwell Int'l Corp., 755 F. Supp. 1468, 1474 (D. Colo.
1991) (following Brewer rationale in denying defendants' motion to dismiss plaintiffs' CER-
CLA claims to recover costs of medical testing to monitor environmental effects of radiation
releases, but granting motion to dismiss for all other medical testing costs under CERCLA);
Lykins v. Westinghouse Elec. Corp., 27 Env't Rep. Cas. (BNA) 1590 (E.D. Ky. 1988) (adopt-
ing Brewer rationale).
68. 750 F. Supp. 1233 (M.D. Pa. 1990).
69. Id. at 1244 (quoting Coburn v. Sun Chem., 19 Envtl. L. Rep. (Envtl. L. Inst.) 20,256,
20,258 (E.D. Pa. Nov. 9, 1988)).
70. 21 Envtl. L. Rep. (Envtl. L. Inst.) 20,677 (E.D. Ark. Nov. 14, 1990).
71. Id. at 20,678. Other cases in which district courts have refused to allow recovery of
medical monitoring costs under CERCLA include Woodman v. United States, 764 F. Supp.
1467, 1470 (M.D. Fla. 1991) (emphasizing that medical monitoring costs for individual plain-
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In October 1986 Congress passed the Superfund Amendments
Reauthorization Act (SARA),7 2 which contained sweeping revisions of
CERCLA, including the establishment of a new taxing mechanism and
requirements for more stringent cleanup standards, site evaluations, and
health risk evaluations. 73 SARA authorized the creation of a new
Agency for Toxic Substances and Disease Registry (ATSDR), whose job
is to perform health assessments on every waste disposal site on the Na-
tional Priorities List to investigate the possibility of disease arising out of
hazardous waste sites.74 While the information generated by the
ATSDR eventually might be used by toxic exposure litigants in pursuing
their claims, the legislation does not provide compensation for toxic ex-
posure victims' medical monitoring.
The need for work place medical surveillance has recently been ad-
dressed in different fora. The International Labor Organization (ILO) at
a June 1990 conference adopted the texts of a convention and a recom-
mendation concerning the safe use of chemicals in the work place.75 The
recommendation emphasized the need for employers to limit workers'
exposure to hazardous chemicals and stated that employers should be
responsible for medical surveillance of prospective health hazards.76
Four democratic legislators recently proposed the Comprehensive Occu-
pational Safety and Health Reform Act, which would encourage employ-
ers and employees to take an active role in identifying potential hazards
before injuries and illnesses occur, rather than focusing on inspections
and the threat of civil fines as the current Occupational Safety and
Health Act (OSHA) does.77 The OSHA reform legislation would require
tiffs are not recoverable under CERCLA); Werlein v. United States, 746 F. Supp. 887, 904-05
(D. Minn. 1990) (holding medical monitoring costs not recoverable as response costs under
CERCLA, but recoverable as common law tort claims); States v. BFG Electroplating & Mfg.
Co., 4 Toxics L. Rptr. (BNA) 1333 (W.D. Pa. 1990) (holding medical monitoring costs not
recoverable); Coburn v. Sun Chem. Corp., 28 Env't. Rep. Cas. (BNA) 1665, 1671 (E.D. Pa.
1988) (concluding that medical screening and monitoring are not "necessary costs of response"
under CERCLA § 107).
72. Pub. L. No. 99-499, 100 Stat. 1613 (1986) (codified at scattered sections of 10, 26, 29,
33, and 42 U.S.C. (1988)).
73. William H. Black, Jr., Toxic and Hazardous Substances and Environmental Law: An-
nual Survey, 25 TORT & INS. L.J. 487, 498 (1990).
74. 1 AMERICAN LAW INST., supra note 9, at 331-32 (citing 42 U.S.C. § 9604(c) (1988)).
See generally Timothy B. Atkeson et al., An Annotated Legislative History of the Superfund
Amendments and Reauthorization Act of 1986 (SARA), 16 Envtl. L. Rep. (Envtl. L. Inst.)
10,363, 10,375-76, 10,392-93 (1986) (discussing ATSDR's broad authority to perform toxicity
profiles, test hazardous substances, and conduct health assessments at Superfund sites). The
National Priorities List is the list generated by the EPA pursuant to CERCLA of states most
in need of cleanup.
75. ILC Adopts Texts, supra note 4, at A-10.
76. 1d.
77. See Democrats' OSHA Reform Bill Requires Employer-Employee Safety Committees,
Daily Rep. for Exec. (BNA), at A-14 (Aug. 2, 1991) (discussing the bill, H.R. 3160, 102d
Cong., 1st Sess.). The bill's sponsors are Senators Edward Kennedy (D-Mass.) and Howard
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the National Institute for Occupational Safety and Health to submit rec-
ommendations for revisions of permissible exposure limits for toxic sub-
stances at least once every three years. 78 The legislation also would
require the promulgation of standards for exposure monitoring and med-
ical surveillance of employees. 79 The new standards would require em-
ployers to supply some type of surveillance and monitoring programs to
control and mitigate the health effects of exposures.80 In another work
place medical monitoring victory a bankruptcy court approved a settle-
ment that established a voluntary employees' beneficiary association
(VEBA) to provide lifetime diagnostic medical surveillance benefits to
employee participants.8 ' The VEBA was funded with a lump sum pay-
ment from the employer's bankruptcy estate.8 2 The Internal Revenue
Service ruled that reimbursements for medical expenses incurred by
VEBA participants were tax deductible. Although these and similar
work place medical monitoring developments certainly are positive, they
do not replace the need for comprehensive recognition of all toxic expo-
sure victims' right to medical surveillance.
8 3
C. Public Policy Considerations Support a Claim for Postexposure,
Presymptom Medical Surveillance
Under traditional tort doctrine, a plaintiff in a typical personal in-
jury case may recover reasonable medical expenses, past and future,
which she incurs as a result of a demonstrated injury.84 The "avoidable
consequences rule" requires the plaintiff to submit to medically advisable
treatment since failure to do so may bar future recovery for a condition




80. Job Safety: OSHA to Continue Broadening Scope of Worker Protection, DAILY REP.
FOR EXECUTIVES (BNA), at S-34 (Jan. 17, 1991).
81. IRS Private Letter Rulings: DER No. 224, Daily Rep. for Exec. (BNA), at K-15
(Nov. 20, 1990).
82. Id.
83. Despite positive developments in the work place, some employers may not cooperate
with efforts to protect workers' health. For instance, when a 50 year-old mechanic at the Oak
Ridge National Laboratory, a nuclear laboratory, appeared on a CBS News program to talk
about the incidence of cancer, including his own, at the lab, executives of the Martin-Marietta
Subsidiary, which runs the lab, retaliated. The Labor Department ruled that the employer
violated several laws and discriminated against the mechanic when it assigned him to do
busywork in an isolated room containing toxic and radioactive chemicals, an assignment that
threatened the employee's already failing health. In Harm's Way, N.Y. TIMES, Feb. 9, 1992,
at E7.
84. CHARLES T. MCCORMICK, HANDBOOK ON THE LAW OF DAMAGES § 90 (1935); see,
e.g., Hagerty v. L & L Marine Servs., Inc., 788 F.2d 315, 319, modified, 797 F.2d 256 (5th Cir.
1986).
[VCol. 43
the plaintiff could have alleviated or avoided. 85 The extension of these
two tort doctrines-the allowance of prospective medical expense dam-
ages and the avoidable consequences rule-provides the foundation for
permitting a claim for future medical surveillance expenses.86 Based on
this foundation, a steadily increasing number of courts have recognized
medical surveillance expenses as an independent element of damages.
87
These courts have relied heavily on public policy considerations in justi-
fying claims for postexposure, presymptom medical surveillance.
Friends for All Children v. Lockheed Aircraft Corp. 88 is an early case
recognizing the need for such a claim. Friends for All Children, the legal
guardian for Vietnamese orphans who survived an airplane crash, alleged
that as a result of the decompression of the plane compartment and the
crash itself, the children suffered from a neurological disorder called
Minimal Brain Dysfunction (MBD).89 Although this was not a toxic tort
case, the court, in determining whether or not to grant a preliminary
injunction, faced many of the same considerations that arise in toxic tort
litigation. Friends for All Children requested a preliminary injunction to
require the defendant to pay for diagnostic examinations and medical
treatment pending the outcome of the trials90 on the merits. The district
court declared that the preliminary injunction was "extraordinary re-
lief," and relied on several public policy factors in granting it:91 First,
the plaintiffs had no adequate remedy at law because the extreme delay
85. The avoidable consequences rule is the tort doctrine that requires plaintiffs to take
any available remedial steps in order to mitigate damages. MCCORMICK, supra note 84, § 33.
See also Hagerty, 788 F.2d at 319.
86. Slagel, supra note 2, at 862-63.
87. Cases in which medical surveillance expenses were recognized as an independent ele-
ment of damages include Hagerty, 788 F.2d at 319 (stating that "the reasonable cost of those
checkups [to ensure early detection and treatment of exposure-related disease] may be included
in a damages award to the extent that, in the past, they were medically advisable and, in the
future, will probably remain so"); Herber v. Johns-Manville Corp., 785 F.2d 79, 83 (3d Cir.
1986) (stating that "New Jersey recognizes the cost of preventative monitoring occasioned by a
tort as an independent element of damages"); Friends for All Children v. Lockheed Aircraft
Corp., 746 F.2d 816, 826 (D.C. Cir. 1984) (stating that "when a defendant negligently invades
this interest [in avoiding expensive diagnostic examinations] ... it is elementary that the de-
fendant should make the plaintiff whole by paying for the examinations") (footnote omitted);
Johnson v. Armstrong Cork Co., 645 F. Supp. 764, 769 (W.D. La. 1986); Ayers v. Jackson
Township, 106 N.J. 557, 606, 525 A.2d 287, 312 (1987) (holding that "the cost of medical
surveillance is a compensable item of damages where the proofs demonstrate ... that such
surveillance . . . is reasonable and necessary"); Askey v. Occidental Chem. Corp., 477
N.Y.S.2d 242, 247, 102 A.D.2d 130 (App. Div. 1984) (stating that "[t]he future expense of
medical monitoring, could be a recoverable consequential damage provided . . . that such
expenditures are 'reasonably anticipated' to be incurred by reason of [plaintiffs'] exposure").
88. 746 F.2d 816 (D.C. Cir. 1984).
89. Id. at 819.
90. The case before the court was a test case. Other trials would likely follow pending the
resolution of the test case.
91. Friends for All Children, 746 F.2d at 822.
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of the complex litigation would render an ultimate damage award inade-
quate to remedy the immediate medical surveillance needs of the plain-
tiffs; second, the societal interest in fostering public health would be
undercut by leaving undiagnosed the children's potentially deteriorating
medical condition; requiring the defendant to pay for diagnostic exami-
nations increased the possibility of early detection and treatment, which
could reduce the amount of compensatory damages the defendant would
have to pay in the long run; and finally, the injunction would serve the
public interest because the examination would produce hard medical
data on the children's condition, which would aid in the resolution of the
litigation.
On appeal, the appellate court rejected Lockheed's implicit claim
that having to undergo diagnostic examinations does not in itself consti-
tute an injury.92 The appellate court held that tort law should compen-
sate plaintiffs for diagnostic examination without proof of actual injury.
93
The court determined that:
A cause of action allowing recovery for the expense of diagnostic ex-
aminations... will, in theory, deter misconduct .... The cause of
action also accords with commonly shared intuitions of normative jus-
tice which underlie the common law of tort .... The [defendant],
through his negligence, caused the plaintiff... to need specific medical
services-a cost that is neither inconsequential nor of a kind the com-
munity generally accepts as part of the wear and tear of daily life.
94
The court also noted that the expense of medical services could deter
exposed individuals from seeking treatment when it stated that "medical
expenses running into the thousands of dollars would likely constitute a
formidable obstacle to families of moderate means."'95
Ayers v. Jackson Township96 was the first toxic exposure case in
which a state's highest court upheld a jury verdict awarding the plaintiff
future medical surveillance costs. 97 The plaintiffs were residents who
sued their township for damages sustained when their well water was
contaminated. Toxic pollutants had leached into the local aquifer from
the township landfill. The original jury verdict compensated the plain-
tiffs for the future cost of medical surveillance to monitor for the onset of
92. IAl at 826.
93. Id. at 825. The court discussed a hypothetical in which Jones, a pedestrian, is hit by
Smith, a motorbike rider. Doctors recommend that Jones undergo a battery of tests to deter-
mine whether he has suffered any internal injuries. Even if the tests prove that Jones sustained
no physical injuries, he should be able to recover the cost of the diagnostic exams, the need for
which was proximately caused by Smith's negligence. Id.
94. Id. at 825.
95. Id. at 836.
96. 106 N.J. 557, 525 A.2d 287 (1987).
97. The Ayers case has been discussed widely by legal commentators. See, e.g., McNa-
mara, supra note 7, passim
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cancer and other diseases. 98 The appellate division set aside the award of
medical surveillance expenses after determining that the claim was too
speculative to warrant recognition.99 According to the appellate divi-
sion, it was "impossible to say that [the] defendant ha[d] so significantly
increased the 'reasonable probability' that any of the plaintiffs will de-
velop cancer so as to justify imposing upon [the] defendant the financial
burden of lifetime medical surveillance for early clinical signs of
cancer."100
The New Jersey Supreme Court criticized the appellate division's
reversal of the medical surveillance award because, under the appellate
division ruling, any plaintiff who obtains regular or periodic medical sur-
veillance to detect adverse health consequences of her toxic chemical ex-
posure personally bears the expense.10 1 The supreme court cited the
"important public health interest in fostering access to medical testing
for individuals whose exposure to toxic chemicals creates an enhanced
risk of disease," particularly in light of the value of early diagnosis and
treatment for cancer patients.102 The court emphasized that the expense
of regular medical testing could deter individuals from receiving neces-
sary medical treatment:
Although some individuals exposed to hazardous chemicals may seek
regular medical surveillance whether or not the cost is reimbursed, the
lack of reimbursement will undoubtedly deter others from doing so.
An application of tort law that allows post-injury, pre-symptom recov-
ery in toxic tort litigation for reasonable medical surveillance costs is
manifestly consistent with the public interest in early detection and
treatment of disease.1
03
The court also cited other public policy considerations, such as the deter-
rence value of allowing medical surveillance claims. 04 Once polluters
were subject to significant liability, they would be more willing to incur
the expense of proper disposal rather than the expense of protracted liti-
gation and payment of medical surveillance claims. Finally, the court
determined that "it is inequitable for an individual, wrongfully exposed
98. The original jury verdict also provided compensation for emotional distress caused by
knowledge of ingesting contaminated water and the deterioration of quality of life during the
period when the residents were deprived of running water. A claim for "enhanced risk" of
cancer was denied by the trial court. This denial was affirmed by the appellate division and the
New Jersey Supreme Court on the grounds that it was too speculative. Ayers, 106 N.J. at 578,
525 A.2d at 297.
99. 202 N.J. Super. 106, 122, 493 A.2d 1314, 1322-23 (1985).
100. I., 493 A.2d at 1322 (citation omitted).
101. Ayers, 106 N.J. at 579, 525 A.2d at 298.
102. Id. at 603, 525 A.2d at 311.
103. Id. at 604, 525 A.2d at 311.
104. Id. at 604, 525 A.2d at 311-12.
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to dangerous toxic chemicals... to have to pay his own expenses when
medical intervention is clearly reasonable and necessary.
'10 5
Legal commentators, as well as a number of courts, have long advo-
cated the recognition of a claim for presymptom, postexposure medical
surveillance based on public policy grounds. 10 6 Commentators cite the
following as some of the potential benefits of requiring toxic tortfeasors
to pay for the ongoing medical surveillance of exposure victims: (1) The
provision of medical monitoring services to those who would otherwise
be unable to afford them; (2) the production of information regarding
the health consequences of human exposure to particular toxic sub-
stances; 107 and (3) the deterrence of future toxic torts as a result of po-
tentially costly liability for ongoing medical surveillance.108
The legal system is playing catch-up with the medical and scientific
communities by recognizing the individual and public benefits of early
diagnosis of toxic exposure-related diseases.109 As the legal community
adapts by permitting toxic exposure victims to pursue medical surveil-
105. Id. at 604-05, 525 A.2d at 312.
106. See, ag., 2 AMERICAN LAW INST., supra note 9, at 376-77 (stating that "both tradi-
tional tort and modem public health rationales support awarding [medical monitoring] dam-
ages"); Gara, supra note 7, at 267-72 (arguing that forcing hazardous substance actors to pay
for the medical surveillance of the toxic victims promotes the goals of deterring future tortious
conduct and mitigating the potential harm suffered by exposure victims); McNamara, supra
note 7, at 353-54; Slagel, supra note 2, at 856-57. See also Strand, supra note 7, at 610-12
(asserting that a social deterrence objective should be the basis for toxic tort compensation).
107. Periodic testing, if conducted as part of a formal settlement or judgment program,
can be used not only to monitor the health of exposure victims but also to gather data on the
health consequences of exposure to particular toxins. This data then can be used to prove
causation in subsequent litigation involving the toxic substance. See Gara, supra note 7, at
270-71.
108. Because the legal and practical barriers to recovery discourage toxic tort victims from
vindicating their rights, toxic substance manufacturers and disposers have little economic in-
centive to prevent or control exposure to toxic substances. Slagel, supra note 2, at 856-57. See
also Strand, supra note 7, at 598-99 (stating that current regulations set out in CERCLA and
RCRA actually reduce the deterrence factor; because toxic producers and disposers are pro-
tected from future liability as long as they comply with current regulations, there is little incen-
tive for toxic firms to adopt additional protective measures).
109. In their July 30, 1990 memorandum in response to Rockwell's motion to dismiss, the
Cook plaintiffs highlighted this point when they stated, "Medical testing and preventive moni-
toring are a traditional form of medical surveillance for purposes of prevention, early detection
and treatment of disease before it becomes manifest." Plaintiffs' Memorandum in Response to
Defendant's Motion to Dismiss at 8-9, Cook v. Rockwell Int'l Corp., 755 F. Supp. 1468 (D.
Colo. 1991) (No. 90-B-181) (citations omitted). In supporting this proposition, the plaintiffs
cited numerous medical studies that supported the need for medical testing and preventive
monitoring of heart disease. Id. The plaintiffs continued:
Moreover, in a growing trend, medical science has come to rely increasingly on so-
phisticated epidemiological and health surveys of populations at risk of disease and
on other scientific studies to estimate risk potential for disease, for purposes of pre-
vention, early detection and to enhance the prospects for cure and treatment.
Id. at 10 (citations omitted).
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lance claims, the players will have to decide whether medical monitoring
damages should be paid in a lump sum at the conclusion of the litigation
or periodically out of a court-supervised fund or similar mechanism.
II. A Framework for Periodic Payments
I10
The common law system provides for a single lump sum payment
for all past, present, and prospective losses stemming from an injury in a
typical tort case. 1 Critics of the traditional lump sum award believe
that periodic payment plans are a more appropriate means of dispensing
future damages awards to plaintiffs, particularly when used in personal
injury cases.112 Proponents of periodic payments envision a variety of
plans, limited only by the creativity of the parties responsible for design-
ing them.1
13
In most tort cases an award of money damages is final because, ab-
sent express legislation to the contrary, the single recovery rule mandates
that damages be paid in a single unalterable sum.1 14 While the source of
the principle prohibiting a court, on its own authority, from entering a
periodic payment judgment is unclear, some commentators attribute the
110. In Structured Settlements and Periodic Payment Judgments, Daniel W. Hindert,
Joseph J. Dehner, and Patrick J. Hindert distinguish the phrases "structured settlement" and
"periodic payment." HINDERT ET AL., supra note 37, § I, at 5. While the phrase "structured
settlement" has often been used to refer to periodic arrangements, the authors prefer "periodic
payment" for the following reasons: (1) it applies to judgments, as well as settlements; (2) it
does not require the use of an annuity, whereas "structured settlements" have been associated
primarily with life insurance annuities; (3) the Internal Revenue Code uses the phrase
"periodic payment" in addressing tax consequences of such arrangements; and (4) the Model
and Uniform Periodic Payment of Judgments Acts use the term "periodic payment." Id. See
also Charles F. Krause, Structured Settlements for Tort Victims, 66 A.B.A. J. 1527, 1527
(1980). Krause uses the term "structured settlements" to indicate voluntary, rather than
compulsory periodic payment plans. Id at 1529. However, "periodic" payments and
"structured" payments or awards are more often used as synonyms. Elligett, supra note 22, at
130 n.3.
111. JOHN G. FLEMING, THE LAW OF TORTs 201 (4th ed. 1971); 4 FOWLER V. HARPER
ET AL., THE LAW OF TORTS § 25.2 (2d ed. 1986).
112. See Krause, supra note 110 (encouraging the use of periodic payments in the settle-
ment context); Samuel A. Rea, Jr., Lump-Sum Versus Periodic Damage Awards, 10 J. LEGAL
STUD. 131 (1981); Barbara Balzer Kolbach, Comment, Variable Periodic Payments of Dam-
ages: An Alternative to Lump Sum Awards, 64 IOWA L. REV. 138 (1978); see also 1990 UNIF.
PERIODIC PAYMENT OF JUDGMENTS ACT, Prefatory Note, 14 U.L.A. 5 (West Supp. 1991);
1980 MODEL PERIODIC PAYMENT OF JUDGMENTS ACT, Commissioners' Prefatory Note, 14
U.L.A. 141 (West 1980).
113. See infra section II.C. (discussing the mechanics of periodic payments).
114. See, e.g., Frankel v. United States, 321 F. Supp. 1331, 1341 (E.D. Pa. 1970), afld sub
nom. Frankel v. Heym, 466 F.2d 1226 (3d Cir. 1972) (stating that although a periodic award
would be more just, the court was precluded from making a periodic award in the absence of
express legislative authorization); cf. Elligett, supra note 22, at 132 (stating that the need for
legislation permitting periodic payments is generally recognized).
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doctrine to practicality and risk.1 15 Notwithstanding the general rule,
judicial and legislative precedents for implementing periodic payments
exist that illustrate departures from the single recovery rule.
A. Judicial Departures From the Single Recovery Rule
In the English case of Jenkins v. Richard Thomas & Baldwin Ltd. 1
16
the court reluctantly departed from the single recovery rule when it per-
mitted the reopening of a damages award. The plaintiff was an injured
employee who the defendant employer had agreed to employ as a grinder
after the trial. The court considered the plaintiff's future earnings as a
grinder in assessing the damages award. Immediately after trial, the de-
fendant refused to hire the plaintiff as a grinder. The court reopened the
case to adjust the damages award because the plaintiff was able to show
that the damages had been wrongly assessed.'
17
American courts have strayed from the traditional lump sum dam-
ages awards in a scant handful of cases. In a 1972 case, Holden v. Con-
struction Machinery Co.," s the Iowa Supreme Court affirmed the trial
court's decision to retain jurisdiction over the case and to periodically
assess the amount of damages owed by the defendant, rather than grant-
ing specific performance in a breach of contract case. The plaintiff, Herle
H. Holden, and the defendant, Warren Holden, were brothers who
owned a manufacturing business. The brothers made a contract, which
provided that, while Warren would retain two more shares of the com-
pany stock, Herle would receive equal compensation as an employee of
the company. When Warren breached the contract in 1968, Herle sued
for specific performance. The trial court denied Herle's request for spe-
cific performance-employment with the company-because of the
brothers' strained relationship.1 19 Instead, it awarded Herle damages
equal to Warren's income from the company. Because the court could
not determine with an acceptable degree of precision the amount of fu-
ture damages, it retained jurisdiction to assess annually the amount owed
to Herle.120 The Iowa Supreme Court, by affirming the periodic assess-
115. HINDERT ET AL., supra note 37, § 1, at 7-8. Judges may be wary of the need for
ongoing supervision and may be reluctant to deal with practical matters, such as deciding
when the payments are to be made and for how long. Judges also may be unwilling to order
plaintiffs to bear the risk that a defendant may become insolvent prior to meeting her obliga-
tion to the plaintiff. Id.
116. [1966] 1 W.L.R. 476 (Eng. C.A.) Barbara Balzer Kolbach discusses this case in her
Comment, supra note 112.
117. Jenkins, [1966] 1 W.L.R. at 479-80.
118. 202 N.W.2d 348 (Iowa 1972). For a discussion of this case, see Kolbach, supra note
112, at 140-41.
119. Holden, 202 N.W.2d at 364.
120. Id.
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ment and payment of damages, recognized the limits of the lump sum
method.
While the Holden court awarded periodic payments in a breach of
contract setting, at least two American courts have permitted periodic
payment of personal injury judgments in the absence of statutory gui-
dance. In M & P Stores v. Taylor, 121 a customer sued a store owner for
negligently failing to maintain safe premises. After the jury was dis-
charged, the defendant objected to the form of the $36,000 verdict. The
jury had determined that the $36,000 was to be paid in $150 monthly
installments over twenty years. Although the Oklahoma Supreme Court
viewed the verdict as improper, it held that the trial court properly per-
mitted the periodic payment plan because no timely objections were filed
prior to the dismissal of the jury.122 In McGhee v. McGhee, 123 the de-
fendant fraudulently induced a woman to marry him. The Idaho
Supreme Court, relying on equity jurisdiction, upheld the trial court's
order that the defendant pay damages in installments.
124
Because settlements are private contractual agreements, they have
not been restricted by the single recovery rule.125 While there is no rec-
ord of the first periodic payment settlement, one theory proposes that the
first periodic payment settlement occurred when an injured plaintiff,
faced with an insolvent defendant, took a promise from the defendant to
pay over time, rather than pursuing the claim in bankruptcy.
126
The first reports of periodic payments to settle personal injury cases
arose in the 1960s as Richardson Merrill, the manufacturer of
Thalidomide, settled claims filed on behalf of Canadian children born
with birth defects. 127 Because Richardson Merrill had no insurance for
the claims, it settled by agreeing to pay the victims over the course of
their lifetimes, rather than through one-time cash payouts.128
Use of periodic payment settlements in the United States has in-
creased steadily over the past two decades, and is now commonplace in
personal injury practice.129 Commentators attribute the increased use to
121. 326 P.2d 804 (Okla. 1958).
122. The court felt the jury should not have rendered a periodic payment verdict on its
own initiative. Id. at 808-09.
123. 82 Idaho 367, 353 P.2d 760 (1960).
124. Id. at 764, 353 P.2d at 764.
125. HINDERT ET AL., supra note 37, § 1, at 13.
126. Id. § 1, at 13-14.
127. Id. § 1, at 14.
128. The payments were backed by annuities scheduled to increase in amount each year by
two percent. Id.
129. That structured settlements are commonplace is evidenced by the existence of the
National Structured Settlements Trade Association. Structured settlement specialists are em-
ployed by insurance companies and attorneys involved in negotiating structured settlements.
In addition, computer software is available to assist attorneys in setting up structured settle-
ment plans. See Michael A. Hanna, Computer Knowledge: Not Just for Your StaffAny More,
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two factors: fst, several Internal Revenue Service rulings awarded tax-
free status to the full amount of periodic payment settlements, which
meant that plaintiffs would suffer no tax disadvantage in accepting peri-
odic payments; second, the increase in the size of personal injury awards
encouraged defendants and their insurance companies to examine alter-
natives to the lump sum damage award.
130
B. Legislative Departures From the Single Recovery Rule
Early legislative attempts to require periodic payments in all tort
cases involving bodily injury failed to gain widespread support. For in-
stance, through eight tentative drafts, the 1980 Model Periodic Payment
of Judgments Act' 3 ' was referred to as a "Uniform Judgments Act."
The change from the designation "uniform act" to "model act" in the
final draft indicates the lack of significant support for the proposed legis-
lation in most jurisdictions.' 32 The prefatory note to the 1990 Uniform
Periodic Payment of Judgments Act highlights the fact that periodic pay-
ment statutes did become more popular subsequent to the 1980 Model
Act: "The Conference approved the Model Periodic Payment of Judg-
ments Act in 1980. At that time approximately 14 states had adopted
some type of [periodic payment legislation] .... Today over 30 states
have adopted some type of periodic-payment legislation."
' 133
Currently, most states have passed statutes permitting or requiring
periodic payments in specific types of cases, such as alimony and child
support, 134 no-fault automobile liability, 135 medical malpractice, 136 and
MICH. LAW. WKLY., Oct. 28, 1991, Supp., at 3B (discussing PI Economist and Structured
Settlement TM, two new computer programs); Barry D. Bayer & Benjamin H. Cohen, THE
RECORDER, Oct. 2, 1991, at 12 (evaluating two new computer programs-Determining Dam-
ages: Structured Settlements and PercentEdge). Statistics from the United States Justice De-
partment (Torts Branch of the Civil Division) indicate that, as of 1988, the United States had
participated in approximately 500 periodic payment settlements. HINDERT ET AL., supra note
37, § 1, at 15.
130. HINDERT ET AL., supra note 37, § 1, at 16.1.
131. 1980 MODEL PERIODIC PAYMENTS OF JUDGMENTS ACT, 14 U.L.A. 141 (West
1990).
132. See Phillip H. Corboy, Structured Injustice: Compulsory Periodic Payment of Judg-
ments, 66 A.B.A. J. 1524, 1526 (1980).
133. 1990 UNIF. PERIODIC PAYMENT OF JUDGMENTS AcT, Prefatory Note, 14 U.L.A. 5,
14-16 (West Supp. 1991). For a complete discussion and listing of the states and the specific
statute citations, see HINDERT ET AL., supra note 37, § 10 & app. C.
134. The typical family support statutes provide for periodic payment of spousal and child
support. These statutes permit courts to retain jurisdiction to modify the periodic payments
upon proof of changed circumstances, such as remarriage or death. See HINDERT ET AL.,
supra note 37, § 1, at 9; White, supra note 22, at 32 n.216.
135. See Elligett, supra note 22, at 133 (observing that "a form of periodic payments is
now used under many no-fault automobile insurance statutes"). If an accident victim seeks the
allowable no-fault benefits directly from her insurer, the benefits may be paid periodically.
HINDERT ET AL., supra note 37, § 1, at 10. See also Kolbach, supra note 112, at 148 n.75
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workers' compensation. 137 At least sixteen states' periodic payment stat-
utes pertain to personal injury actions in general. 138 However, no state
has enacted periodic payment legislation specifically dealing with medi-
cal surveillance claims in toxic tort litigation. When courts have created
medical surveillance funds to compensate toxic exposure victims on a
periodic basis, they have done so in the absence of legislative guidance.
Some of these courts have relied on the equitable power of courts to
adapt the relief granted to the circumstances of the particular case.
139
And, while periodic payment plans are now commonplace in other areas
of litigation, there have been relatively few set up for medical surveillance
purposes.14°
C. The Mechanics of Periodic Payments
Various periodic payment plans have been implemented by statute
and suggested by commentators.141 This section examines a few of the
ways in which these periodic payment plans differ. Usually, losses al-
(noting that at least six states allow for payments of benefits as loss accrues under no-fault
automobile accident compensation plans).
136. At least twenty state statutes provide for periodic payments in actions against health
care providers. See Henderson, supra note 18, at 27-28 & nn.24-43 (listing 20 states and citing
specific statutes that provide for periodic payments in medical malpractice actions); Larry S.
Milner, Comment, The Constitutionality of Medical Malpractice Legislative Reform: A Na-
tional Survey, 18 Loy. U. CHI. L.J. 1053, 1067 n.96 (1987) (listing 17 state statutes providing
for periodic payments in actions against health care providers). For a complete analysis of a
periodic payment statute limited to medical malpractice actions, see Henderson, supra note 18,
discussing Arizona's statute and recommending that it be used as a prototype.
137. Workers' compensation statutes typically require periodic payments. Future pay-
ments are subject to increase, decrease, termination, or revival. HINDERT ET AL., supra note
37, § 1, at 9. These statutes may contain provisions for converting periodic payments to lump
sums in exceptional circumstances. See, e.g., MONT. CODE ANN. §§ 39-71-740, 39-71-741
(1991), discussed in Teresa Thompson, A Checklist for Drafting a Petition for Lump-Sum Con-
version of Permanent Partial Workers' Compensation Benefits, 47 MONT. L. REV. 177 (1986).
The Montana statute is typical in that it mandates the payment of benefits in biweekly install-
ments. An injured worker may petition to have her award converted to a lump sum by submit-
ting a written request demonstrating that her ability to sustain herself financially is more
probable with a whole or partial lump sum payment. Thompson, supra, at 177-78.
138. Henderson, supra note 18, at 28; see, e.g., WASH. REV. CODE ANN., § 4.56.260 (West
1988). For a detailed analysis of Washington's periodic payment provisions, see Donovan
Flora, Periodic Payment of Judgments in Washington, 22 GONZAGA L. REv. 155 (1986-87)
(concluding that the Washington statute is flawed and unfair to tort victims).
Examples of periodic payment plans may be found in foreign countries, as well. France,
Australia, New Zealand, and Great Britain all have statutes mandating periodic payments in
some circumstances. HINDERT ET AL., supra note 37, § 1, at 10-11.
139. See supra note 25 and accompanying text.
140. One structured settlement specialist indicated that, while he has set up structured
settlements on many occasions, he has yet to see a structured settlement implemented for
medical surveillance purposes. Telephone Interview with H.R. Brandell, Settlement Advisors,
Inc. of Englewood, Colo. (Nov. 12, 1991).
141. See, e.g., 1990 UNIF. PERIODIC PAYMENT OF JUDGMENTS ACT, 14 U.L.A. 5 (West
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ready incurred are paid in full in a lump sum and future losses are paid
under a plan. 142 Periodic payment plans may be used in dispensing judg-
ments or settlements, and may be administered as a trust or financed
with annuities. 143 The plans can be discretionary or mandatory. 144 If
discretionary, plans differ as to who may elect to use a periodic plan, and
whether all of the parties involved in the litigation must agree to the
plan. 145 Section 6(3) of the 1980 Model Periodic Payment of Judgments
Act established a $100,000 threshold of net damages; if this threshold
was met, the Act mandated periodic payments. 146 If the total amount
was less than $100,000, then the Act required a lump sum payment, un-
less the claimant or the beneficiaries elected to receive periodic
installments. 147
Because periodic payments are mandatory under most states' work-
ers' compensation statutes,1 48 injured workers under these statutes have
no right to reject periodic payments. In fact, many of the workers' com-
Supp. 1991); 1980 MODEL PERIODIC PAYMENT OF JUDGMENTS ACT, 14 U.L.A. 141 (West
1990); Elligett, supra note 22; Kolbach, supra note 112.
A detailed examination of the ins and outs of periodic payments is beyond the scope of
this Note. The reader may refer to the following sources for more detailed information: ECK
& UNGERER, supra note 21; HINDERT ET AL., supra note 37; Elligett, supra note 22.
142. Elligett, supra note 22, at 131.
143. Structured settlements have been used for almost 20 years and have become more
commonplace in cases involving physical illness and injury. A structured settlement is a settle-
ment that bundles annuities and guaranteed lump sum payments into a single settlement pack-
age. Leslie A. Shipley, Structured Settlements Benefit Both Parties, MICH. LAW. WKLY., June
24, 1991, at 7B.
An annuity is a contract or policy sold by insurance companies to provide payments at a
future time. Joseph Kelner & Robert S. Kelner, Trends in CPLR Articles 50A4 and SOB, N.Y.
L.J., August 27, 1991, at 3 [hereinafter Kelner & Kelner, Trends].
144. For example, workers' compensation and family support statutes mandate periodic
payments, while some statutes simply permit periodic payments in other contexts.
145. For instance, § 3 of the 1980 MODEL PERIODIC PAYMENT OF JUDGMENTS ACT, 14
U.L.A. 141, 148 (West 1990), allowed any party to an action for bodily injury to make an
election for periodic payments. Any party could object within 30 days after notice of the other
party's election. Section 2 of the 1990 UNIFORM PERIODIC PAYMENT OF JUDGMENTS ACT,
14 U.L.A. 5, 11 (West Supp. 1991), contains similar election provisions. At least one commen-
tator has criticized the election provisions of the 1980 Model Act. He has asserted that, by
placing defendants in superior bargaining positions, the election provisions interfered with
claimants' freedom of contract. Corboy, supra note 132, at 1525 (stating that the "real effect in
most cases will be to allow a defendant to impose the periodic payment device on all other
parties merely by showing that security in the amount of $500,000, regardless of the amount of
damages or the amount of the claim, whichever is less, can be provided").
146. 1980 MODEL PERIODIC PAYMENT OF JUDGMENTS ACT § 6(3). The $100,000 figure
was bracketed in the text of the 1980 Model Act, indicating that individual states could set
their own required minimums. For a discussion of how a threshold should be calculated, see
Elligett, supra note 22, at 135-37.
147. 1980 MODEL PERIODIC PAYMENT OF JUDGMENTS ACT § 6(2). 1990 UNIF. PERI-
ODIC PAYMENT OF JUDGMENTS ACT § 2 contains similar provisions.
148. See supra note 137; Kolbach, supra note 112, at 146.
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pensation statutes restrict the availability of lump sum settlements or
commutations of scheduled payments for which claimants might opt as
alternatives to periodic payments. 149 Many state statutes also mandate
periodic payments in actions against health care providers and in marital
dissolutions. 150
The termination of payments for future losses upon death, with a
partial lump sum payment to the beneficiaries and a partial reversion to
the insurer, is a common feature of periodic payment plans.151 The 1980
Model Act contained this type of provision:
[T]he liability for payment of any installments for medical or other
costs of health care or noneconomic loss not yet due at the death of a
person entitled to receive these benefits terminates upon the death of
that person. The liability for payment of any other installments or
portions thereof not yet due at the death of the person entitled to re-
ceive them likewise terminates .... 152
Section 11 of the 1990 Uniform Periodic Payment of Judgments Act sim-
ilarly provides that "liability to a claimant for periodic payments not yet
due for medical expenses terminates upon the claimant's death."' 153 Ter-
mination provisions of this type have been criticized because, upon the
tort victim's death, payments terminate, rather than remaining a part of
her estate as with lump sum awards.154 With a lump sum award of dam-
ages, the property right vests upon payment so the tort victim's heirs can
take any leftovers. With a periodic payment award, however, the tort
victim does not have a vested property right in future monetary damages
until the costs accrue; since no costs can accrue after the tort victim dies,
the tortfeasor is liable for no further payments. The victim's heirs, there-
fore, do not benefit from leftovers.
The long-term financial strength of the obligated parties directly af-
fects the financial security of the claimants who may depend on periodic
payments for their support over many years.155 Some prominent life in-
surance companies that issued annuities to fund periodic payment plans
have been criticized for investing irresponsibly.15 6 The perceived finan-
149. Kolbach, supra note 112, at 146 n.64 (citing WILLIAM R. SCHNEIDER, THE LAW OF
WORKMEN'S COMPENSATION 1296 (1922); HERMAN SOMERS & ANNE SOMERS, WORKMEN'S
COMPENSATION 161 (1954)).
150. See supra notes 22, 136 and accompanying text.
151. Elligett, supra note 22, at 131.
152. 1980 MODEL PERIODIC PAYMENT OF JUDGMENTS ACT § 11(a), 14 U.L.A. 141, 166
(West 1990).
153. 1990 UNIF. PERIODIC PAYMENT OF JUDGMENTS ACT § 11, 141 U.L.A. 5, 166 (West
Supp. 1991). The 1990 Uniform Act does provide, however, that, in actions other than for
wrongful death, periodic payments for economic losses not yet due at death, other than pay-
ments for medical expenses, must be paid to the estate of the decedent. Id.
154. See Corboy, supra note 132, at 1526.
155. John Jefferies, Structured Settlement Security: Reality or Facade?, 27 TRIAL, Aug.
1991, at 26.
156. Executive Life of New York, a life insurance company that funded many periodic
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cial instability of these companies has raised questions about the long-
term security of periodic payments, particularly structured settlements
funded with annuities. Today, periodic payment statutes and plans con-
tain a variety of security provisions that protect the claimant from the
possible future insolvency of the obligor or the obligor's assignee. 157 One
approach to improving prospects for long-term security has been to re-
quire companies that fund periodic payment plans to meet minimum fi-
nancial standards. Both the 1980 Model Periodic Payment of Judgments
Act and the 1990 Uniform Periodic Payment of Judgments Act contain
extensive security provisions, including the requirement that only "quali-
fied insurers" be used.158
An alternative method of protecting periodic payment recipients is
to grant them preferred creditor status so that they may continue to re-
ceive their periodic payments even if the party responsible for paying
becomes insolvent. Typically, a tort claimant has only general creditor
status and therefore fares poorly once the obligor becomes insolvent. 159
The Arizona periodic payment statute contains a security provision that
grants the plaintiff-judgment creditor rights superior to general
creditors.160
Another important way in which periodic payment proposals vary is
in whether or not they allow for the adjustment of the amount of the
damages award. With a lump sum award, the plaintiff's future losses are
estimated and adjusted for certain factors such as inflation. The plaintiff
then receives a fixed amount in a lump sum. Even if circumstances
change so that the original sum either fails to compensate the plaintiff
adequately, or compensates her for more than her actual future losses,
payment plans, invested over half of its assets in junk bonds. The financial security of other
prominent companies that sold annuity contracts to fund periodic payment plans has weak-
ened. Joseph Kelner & Robert S. Kelner, Life Insurance Industry Stability and Tort Litigators,
N.Y. L.J., Jan. 10, 1990, at 3 [hereinafter Kelner & Kelner, Life Insurance Industry].
157. The Periodic Payment Settlement Act of 1982, 26 U.S.C. § 130 (1988), allowed de-
fendants to assign their future payment obligations to a third party. Jefferies, supra note 155,
at 26. In this arrangement the claimant agrees to accept a new obligor who is informally called
the assignee. Today, over 80% of all annuity-funded structured settlements are treated this
way. Id.
158. See 1990 UNIF. PERIODIC PAYMENT OF JUDGMENTS ACT § 18, 14 U.L.A. 5, Supp.
33 (West Supp. 1991), which directs the Commissioner of Insurance of the adopting jurisdic-
tion to publish a list of "qualified insurers." The qualified insurers must meet minimum stan-
dards designed to protect the periodic payment recipient. Section 9 of the 1980 MODEL
PERIODIC PAYMENT OF JUDGMENTS AT, 14 U.L.A. 141, 161-62 (West 1990), requires each
party liable for all or any part of a periodic payment judgment to post security within 30 days
of judgment, while specifying acceptable forms of security, e.g., bonds and annuities executed
by qualified insurers.
159. See Jefferies, supra note 155, at 28.
160. See Henderson, supra note 18, at 64-65 (discussing the security provision in ARIZ.
REV. STAT. ANN. § 12-588(c) (Supp. 1989).
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the damages award will not be adjusted.161 Some periodic payment plans
merely award an unalterable sum to be paid in installments over a period
of time, rather than in a lump sum. 162 Drafters of the 1980 Model Act
voted to delete provisions that allowed an award for periodic payments
to be modified after the judgment was entered. 163 The 1990 Uniform Act
also contains no provision for modifying periodic payment awards after
judgment is entered. Some supporters of periodic payments have criti-
cized this type of periodic payment plan as being inflexible and no better
than lump sum awards. 164 By contrast, "contingent" or "variable" peri-
odic payment plans allow periodic payment awards to be modified after
judgment (or settlement) to reflect changes in circumstances that arose
after the judgment (or settlement) was entered. 165
D. Why Periodic Payments? 166
Before examining periodic payment plan options for medical surveil-
lance, a general discussion of the advantages and disadvantages of peri-
odic payments is warranted. The use of periodic payments is hailed by
161. See Kolbach, supra note 112, at 142-43 (discussing a pattern of over- and undercom-
pensation for personal injuries resulting from the use of unalterable lump sum awards).
162. This type of plan has been criticized because, rather than dealing with the uncertainty
issue in calculating future losses, an unalterable sum paid over a period of time forces the
victim to spread her consumption over her expected lifetime. See, e.g., Rea, supra note 112, at
148.
163. Kolbach, supra note 112, at 139 n.17.
164. See id The Washington and New York state statutes are examples of statutes that
mandate periodic payments but do not permit modification of damages awards based on future
events. Washington is one of only a handful of states that does not limit periodic payments for
bodily injury to negligence actions against health care providers. WASH. REV. CODE ANN.
§ 4.56.260 (West 1988). Under an earlier version of the Washington statute, a Washington
court could require a fixed sum to be paid over time as an annuity in any civil action in which
the court determined that the plaintiff was totally and permanently disabled. WASH. REV.
CODE ANN. § 4.56.240 (West 1988) (repealed 1986). See Flora, supra note 138, at 171. New
York now mandates periodic payment of judgments for future damages in personal injury,
injury to property, and wrongful death cases when the award exceeds $250,000. N.Y. Civ.
PRAC. L. & R. §§ 5041-5049 (McKinney 1991). Articles 50A (§§ 5031-5039) and SOB
(§§ 5041-5049) of the New York statute require that substantial personal injury awards be
funded by annuity contracts. This provision has been severely criticized since many of the
insurance companies that sold annuity contracts invested the money unwisely. See, e.g., Kel-
ner & Kelner, Life Insurance Industry, supra note 156, at 3 (discussing risks inherent in annu-
ity contracts and fact that Executive Life of New York invested over one half of its assets in
junk bonds); Joseph Kelner & Robert S. Kelner, Trends, supra note 143, at 3 (stating that New
York periodic payment provisions "have proven to be an actuarial nightmare for practicing
attorneys and for judges who must administer them").
165. Barbara Balzer Kolbach advocates variable periodic payment plans in her Comment.
See Kolbach, supra note 112, at 139. State spousal and child support statutes typically use
variable periodic payment plans. See White, supra note 22, at 32 n.216.
166. For a more thorough look at the advantages and disadvantages of periodic payments,
see ECK & UNGERER, supra note 21, chs. 5 & 6 (highlighting reasons why a plaintiff and
defendant would select a structured settlement); HINDERT ET AL., supra note 37, § 1.04
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supporters as the answer to the weaknesses inherent in a lump sum
award of damages. Pitfalls of lump sum payments frequently cited by
commentators include the possibility that a lump sum will inaccurately
compensate a tort victim for future losses;167 that, if a lump sum damage
award exceeds the tort victim's actual losses, society eventually pays for
such windfalls in higher insurance costs; 168 that tort victims will misman-
age large sums of money paid in lump sums; 169 and that income tax pay-
ments on lump sum awards reduce a tort victim's actual
compensation. 170 Proponents of periodic payments argue that periodic
payments insure that tort victims use money from damage awards for
future care and income, rather than for other purposes. 171 Professors
Keeton and O'Connell, in a 1965 book on no-fault auto insurance, dis-
cussed the fact that tort victims rarely invest the awards they recover,
thus failing to provide for their long-term needs.1 72 According to one
commentator, "[m]ismanagement, squandering, and dissipation are not
uncommon."1 73 A 1947 study by the Railroad Retirement Board re-
ported that settlements for work-related injuries were not typically dis-
posed of by injured workers and survivors "to offer assurance of a stable
substitute for the loss of wages incurred in the severe and fatal
injuries." 174
Other commentators reject the assumption that tort victims squan-
der their money. These commentators declare that it is paternalistic to
(highlighting periodic payment advantages and disadvantages to claimants, defendants,
insurers, and plaintiffs' attorneys).
167. See Krause, supra note 110, at 1528 (discussing the inaccurate calculation of future
lost earnings: "[Tihe method of calculation of the present value of future losses does not result
in an award that reflects the true present value of the lost contributions over a projected future
period.").
168. See Elligett, supra note 22, at 146 (citing one insurance company's savings of 35% to
45% when periodic payments were used instead of lump sum awards); Krause, supra note 110,
at 1528 (citing significant benefits to insurers when damages are paid in periodic payments
rather than lump sums).
169. See HINDERT ET AL., supra note 37, § 1, at 21; Elligett, supra note 22, at 131 (citing
the potential for plaintiffs' wasting their lump sum awards and, therefore, becoming wards of
the state as one argument, albeit paternalistic, favoring periodic payments); Krause, supra note
110, at 1527; Kolbach, supra note 112, at 144 ("The inexperienced plaintiff, probably con-
fronted with the largest single amount of money he or she has ever possessed, typically ex-
hausts the award before the loss itself is remedied.").
170. Elligett, supra note 22, at 147 (explaining that interest on lump sum awards is taxed
while periodic payments are tax exempt); Krause, supra note 110, at 1528 (stating that the tax
consequences of lump sum awards might be elusive and lead to dissipation of the
compensation).
171. See supra note 169.
172. ROBERT E. KEETON & JEFFREY O'CONNELL, BASIC PROTECTION FOR THE TRAFFIC
VICTIM-A BLUEPRINT FOR REFORMING AUTOMOBILE INSURANCE 354 (1965).
173. Krause, supra note 110, at 1527.
174. 1 U.S. RAILROAD RETIREMENT BOARD, WORK INJURIES IN THE RAILROAD INDUS-
TRY 1938-1940, at 175 (1947), discussed in Kolbach, supra note 112, at 144.
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force periodic payments on tort victims to prevent them from misman-
aging their damages awards. In rejecting the argument that victims will
squander lump sums of money, a personal injury attorney stated:
I rarely make such an arrangement [for periodic payments] to protect
an adult client from his own supposed weaknesses, because I rarely see
evidence that a client who has received a million dollars in damages
thinks that he is now well-off and can afford the things he could not
afford before. 175
Another commentator argued that "[t]he court might be interested in the
way the victim allocates his award because paternalistically it wishes to
make decisions for the victim because it fears that the victim will become
eligible for welfare benefits if the award is 'misused.' "176
Lump sum awards can result in windfalls for tort victims and their
survivors. When future losses turn out to be less than the amount
awarded, the tort victim gets a windfall. Further, when tort victims die
before the age used to calculate lost earnings, medical expenses, and
other future losses, the victim's survivors achieve a windfall. 177 Critics of
the windfall rationale for periodic payments argue that there has been no
parallel concern when claimants' losses exceed the amount of the dam-
ages award. 178 A contingent or variable periodic payment scheme would
correct this asymmetry by permitting the adjustment of damage awards
that inadequately compensate tort victims for their losses. 179
A major advantage of periodic payments is that they provide a
plaintiff with an opportunity for federal income tax savings, which does
not exist with a lump sum award. 1 0 Under Internal Revenue Code Sec-
tion 104(a)(2), personal injury damages received as a lump sum are ex-
cluded from a claimant's gross income, but the interest realized from
investing the lump sum is not.181 With periodic payments, the claimant
can receive installment payments that increase over time to account for
175. Corboy, supra note 132, at 1524.
176. Rea, supra note 112, at 143.
177. See 1980 MODEL PERIODIC PAYMENT OF JUDGMENTS ACT § 11 commissioners'
comment, 14 U.L.A. 141, 167 (West 1990) (stating that "[s]ince death precludes the accrual of
losses for such items of damage [medical or other health care costs and noneconomic loss such
as pain and suffering], it was felt that these items would be a windfall to the recipient"); see
also CAL. CIV. PROC. CODE § 667.7(0 (West 1987) (stating that the legislature's intent is to
eliminate "the potential windfall from a lump-sum recovery which was intended to provide for
the care of an injured plaintiff over an extended period who then dies shortly after the judg-
ment is paid, leaving the balance of the judgment award to persons and purposes for which it
was not intended").
178. See Corboy, supra note 132, at 1526. In criticizing the windfall rationale of the com-
missioner's comment to § 11 of the 1980 ModelAct, Corboy states, "If symmetry were a goal,
the drafters would provide a means for reopening the judgment on behalf of the plaintiff as
well as for the defendant. . . ." Id.
179. See, eg., Kolbach, supra note 112, at 139 n.17, 142-43




inflation and accrued interest. These larger sums will be tax free, at least
at the federal level.
182
Critics of periodic payments cite administrative inefficiency as one
reason for rejecting proposals calling for continued review of cases.
183
Proponents of periodic payments counter that the administrative difficul-
ties can be managed effectively and that the cost of administering peri-
odic payment plans is reasonable compared to the benefits.1 84 In
Germany the burden on courts was actually reduced, rather than exacer-
bated, by the introduction of periodic payments into the established dam-
age system.18 5 The New Jersey Supreme Court expressed a practical
approach to the administration of periodic payments in the context of
medical monitoring funds when it stated, "Although there may be ad-
ministrative and procedural questions in the establishment and operation
of such a fund, we encourage its use by trial courts in managing mass-
exposure cases." 186 In a footnote, the court stated:
It is beyond the scope of this opinion to set down guidelines for trial
courts in establishing and administering such funds. A court-ap-
pointed administrator will be required. The cost of administration
should be borne by defendants. A procedure should be established for
the submission and review of claims for payment, and to determine the
availability of collateral source benefits. We are confident that satisfac-
tory procedures can be developed by trial courts on a case-by-case
basis. 
187
It is evident that proponents and critics of periodic payments differ
in their views as to whether periodic payments are a viable alternative to
lump sum payments and who benefits from periodic payment plans. 88 It
182. Henderson, supra note 18, at 32 n.81.
183. See, eg., Rea, supra note 112, at 144 (stating that "[tihe process by which courts
determine fault and the extent of damages is extremely costly, but requiring a continual review
of the cases would be much more so").
184. Kolbach, supra note 112, at 152-53.
185. Id. at 152 (citing John Fleming, Damages: Capital or Rent?, 19 U. TORONTO L.J.
295, 320 (1969)).
186. Ayers v. Jackson Township, 106 N.J. 557, 610, 525 A.2d 287, 314 (1987).
187. _Id at 610 n.14, 525 A.2d at 314 n.14. Courts have exhibited the capacity to respond
creatively to administrative challenges in the past, particularly in large-scale institutional re-
form litigation. See, e.g., William A. Fletcher, The Discretionary Constitution: Institutional
Remedies and Judicial Legitimacy, 91 YALE L.J. 635 (1982) (discussing judges' exercise of
discretion in forging remedies in school desegregation, prison reform, and other institutional
reform cases). The use of magistrates and special masters has enhanced the ability of courts to
respond to administrative challenges. See, e.g., In re Fernald Litig., No. C-1-85-0149 (S.D.
Ohio Sept. 29, 1989); In re Agent Orange Prod. Liab. Litig., 611 F. Supp. 1396 (E.D.N.Y.
1985), cert. denied, 487 U.S. 1234 (1986), ajf'd in relevant part, 818 F.2d 179 (2d Cir. 1987); In
re Three Mile Island Litig., 557 F. Supp. 96 (M.D. Pa. 1982).
188. Kolbach argues that variable periodic payments would benefit plaintiffs and defend-
ants in both contract and tort actions, as well as the general public who would be spared
increased taxes and insurance costs resulting from claimants' mismanagement of lump sum
payments. Kolbach, supra note 112, at 143, 146. Other commentators agree that periodic
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remains undisputed, however, that periodic payment judgments and set-
tlements are more common on the legal landscape than ever before.
Therefore, a look at the ethical and constitutional considerations that
periodic payments raise may prove useful.
E. Ethical Considerations Raised by Periodic Payments
Even proponents of periodic payments recognize that they pose dis-
tinct ethical dilemmas for attorneys. Many plaintiff's attorneys oppose
periodic payment judgments and settlements because of the new respon-
sibilities and potential new professional liability.18 9 While an attorney
whose client receives a lump sum award is not ordinarily responsible for
advising her client of the tax and financial management aspects of the
award, an attorney whose client receives a periodic payment is responsi-
ble for valuating the award to determine its adequacy and for exploring
tax, financial, medical, estate, and other issues with her client.190 Ethical
Consideration 7-8 of the Model Code of Professional Responsibility re-
quires a lawyer to inform and advise a client about all "relevant consider-
ations." 191 Considerations that may be relevant in discussing periodic
payments include tax consequences, the effect inflation will have on the
future value of a periodic payment award, the method in which future
payments will be made, and the degree of risk involved. Thus, an attor-
ney who considers periodic payments a personal inconvenience is still
obligated to thoroughly explore the potential advantages and disadvan-
tages of a periodic payment plan in light of an individual client's
needs. 192
The tension between an attorney's personal interest and her client's
interest has been thrust into the spotlight recently as the following ques-
tion has arisen: When periodic payments are implemented, on what
amount should a lawyer's fee be based?1 93 A periodic payment award
payments benefit plaintiffs, defendants, insurers, and society in general. See HINDERT ET AL.,
supra note 37, § 1; Eiligett, supra note 22, at 149-50. In contrast, Corboy argues that periodic
payment plans "would benefit only one segment of the public, would actually worsen the con-
dition of accident victims, and [have] as [their] only real purpose the facilitation of ever-dimin-
ished costs of operation for liability insurers." Corboy, supra note 132, at 1526.
189. See David Austern, The Ethics of Structured Settlements, 22 TRIAL, Nov. 1986, at 17.
Periodic payments introduce a new level of complexity into a well established system of negoti-
ating and litigating personal injury claims; until forms begin to standardize and knowledge
broadens, complexity will continue to dissuade some attorneys from supporting periodic pay-
ments. See HINDERT ET AL., supra note 37, § 1, at 25.
190. See HINDERT ET AL., supra note 37, § 1, at 24-25.
191. Austern, supra note 189, at 18. See MODEL CODE OF PROFESSIONAL RESPONSIBIL-
ITY EC 7-8 (1980).
192. This obligation applies to plaintiff, defense, and insurance counsel.
193. Plaintiff attorneys frequently enter into contingent fee arrangements with their cli-
ents. While periodic payment plans do not preclude the use of contingent fee arrangements, an
attorney may encounter difficulty calculating the amount of the fee and determining the timing
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"involves two sums, the present value and the future value of the annuity
used to fund the package. 1 94 Plaintiffs frequently retain attorneys on a
contingent fee basis. A standard agreement would provide the attorney
with a one third contingent fee, although variations are not uncommon.
If the case settles, and a structured settlement is implemented, the plain-
tiff's attorney might be tempted to take her entire fee out of the initial
payment and "cash out" of the case, leaving all remaining periodic pay-
ments solely to the client. 195 State bar associations recently have indi-
cated that the collection of the entire contingent fee from the initial down
payment cannot be predicated upon the future value of the total settle-
ment award. 196 The various codes of ethics do not require that a contin-
gent fee be collected either as a lump sum or as a percentage of each
periodic payment.197 Attorneys are free to specify the method to be used
for computing contingency fees in the agreements they enter into with
their clients. In the absence of an express agreement, it is unlikely that
an attorney will be permitted to charge a contingent fee based on the
future payments of a structured settlement rather than on its present
value. Florida Bar v. Gentry198 involved a lawyer who was placed on
probation for doing just that. The Minnesota Supreme Court in Carde-
nas v. Ramsey County'9 9 held that, absent an express written agreement
to the contrary, a lawyer's fees should be received periodically as the
client receives future payments.
The 1990 Uniform Periodic Payment of Judgments Act and state
periodic payment provisions address the attorney fee issue. Section 7(e)
of the 1990 Uniform Act and the Comment following the section set out
detailed guidelines for calculating contingent fee awards when all or part
of a judgment or settlement is to be paid periodically. 200 Section 6146(b)
of the California Business and Professions Code states:
of payment. An attorney should not place her interest in receiving a lump sum fee above her
client's interest in receiving the most advantageous damages award.
For commentary on the issue of attorney's fees and periodic payments, see HINDERT ET
AL., supra note 37, § 1, at 24-25; Austern, supra note 189, at 17; Lawrence A. Dubin, Pay Me
Now or Pay Me for Years, NAT'L L.J., Apr. 9, 1990, at 13.
194. James S. Marello, Comment, Periodic Payment Plans: Are Annuities Adequately Pro-
tecting the Personal Injury Plaintiff rom Inflation, Providing Accurate Attorney's Fees and Pro-
moting the Compensatory Goal of Our Tort Law System?, 12 OHIO N.U. L. REV. 271, 280
(1985).
195. Dubin, supra note 193, at 13.
196. Id. (discussing D.C. Bar Legal Ethics Comm., Op. 208 (1989); Miss. State Ethics
Comm., Op. 92 (1984)).
197. Id. See, e.g., Bus. & PROF. CODE § 6147 (West 1990) (same).
198. 475 So. 2d 678 (Fla. 1985) (holding that the attorney's conduct violated ethical rules
prohibiting lawyers from charging illegal or clearly excessive fees).
199. 322 N.W.2d 191, 194 (Minn. 1982); see Austern, supra note 189, at 17.
200. 1990 UNIF. PERIODIC PAYMENT OF JUDGMENTS ACT § 7(e) & comment, 14 U.L.A.
5, 157 (West Supp. 1991).
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If periodic payments are awarded to the plaintiff pursuant to [Califor-
nia Code of Civil Procedure] Section 667.7... [which mandates peri-
odic payments in actions against health care providers], the court shall
place a total value on these payments based upon the projected life
expectancy of the plaintiff and include this amount in computing the
total award from which attorney's fees are calculated under this
section.2
01
As periodic payments become more commonplace, attorneys will
have to educate themselves about periodic payments to avoid the risk of
professional sanctions and malpractice lawsuits brought by their clients.
Fortunately, standardized forms, practice manuals, and computer
software are available to assist practitioners in learning about, and de-
signing, periodic payment plans. 20 2
F. Can Periodic Payment Plans Withstand Constitutional Scrutiny?
As the use of periodic payments becomes more widespread, courts
and commentators have begun to address the constitutional issues that
arise through their use. The case of Holden v. Construction Machinery
Co. 203 is a rare example of a court ordering periodic payments for future
damages in the absence of a statutory provision for periodic payments.
The New Jersey Supreme Court in Ayers v. Jackson Township,204 in rec-
ommending medical surveillance funds as an alternative to lump sums
for future medical expenses, relied on the equitable power of courts to
fashion appropriate remedies, not on any express statutory grant of au-
thority to order periodic payments. In the areas of spousal and child
support, workers' compensation, medical malpractice, and no-fault auto-
mobile liability, statutes dictate whether periodic payments are
mandatory or permissive.20 5 Opponents of the statutes mandating peri-
odic payments have challenged their validity on due process and equal
protection grounds, because these statutes require periodic payments in
some tort actions but not in others.206 The use of periodic payments in
principle has been upheld, although a few courts have struck down par-
ticular state statutes.207
201. CAL. Bus. & PROF. CODE § 6146(b) (West 1990).
202. ECK & UNGERER, supra note 21, and HINDERT ET AL., supra note 37, are thorough
practice manuals. See also supra note 129 (noting some of the computer programs presently
available to assist attorneys).
203. 202 N.W.2d 348 (Iowa 1972). See supra text accompanying notes 118-120.
204. 106 N.J. 557, 525 A.2d 287 (1987). See supra note 24.
205. See supra notes 134-137.
206. The judicial decisions primarily have addressed the constitutionality of statutes re-
quiring periodic payments in medical malpractice actions. Each decision focuses on particular
features of the challenged legislation and has applied different standards to reach each result.
HINDERT ET AL., supra note 37, § 10, at 41.
207. Id. Cases in which courts have upheld the constitutionality of states' medical mal-
practice statutes requiring periodic payments include Fein v. Permanente Medical Group, 38
Cal. 3d 137, 695 P.2d 665, 211 Cal. Rptr. 368 (1985), appeal dismissed, 106 S. Ct. 214 (1985);
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In American Bank & Trust Co. v. Community Hospital,208 the Cali-
fornia Supreme Court upheld the constitutional validity, under both fed-
eral and state constitutions, of the state's 1975 Medical Injury
Compensation Reform Act. The Act provided that, upon request, a neg-
ligent health care provider could elect to pay awards of future damages
in excess of $50,000 on a periodic basis. In an earlier decision the Court
of Appeal for the First District held that the statute violated state and
federal guarantees of equal protection and due process. 2°9 In reaching its
conclusion, the California Court of Appeal determined that the statute
unconstitutionally singled out personal injury plaintiffs with claims in ex-
cess of $50,000 for distinctive treatment.210 The court found no rational
relation to an appropriate governmental interest which would support
differential treatment. The California Supreme Court reversed the court
of appeal decision. The court observed that a plaintiff has no vested
property right in a particular measure of damages, and that the legisla-
ture has broad authority to modify the scope and nature of damages.
211
The court rejected the plaintiff's argument that the statute was not ra-
tionally related to legislative purpose. The court observed that the legis-
lation was rationally related to the intended purpose of reducing
skyrocketing medical malpractice premiums and health care costs, as
well as assuring the availability of funds to malpractice victims as they
were needed.212 According to the court, a statute that created a privi-
leged class of tort defendants, i.e., negligent health care providers, did
not violate equal protection, because the statute was a reform measure
American Bank & Trust Co. v. Community Hosp., 36 Cal. 3d 359, 683 P.2d 670, 204 Cal.
Rptr. 671 (1984); Florida Patient's Compensation Fund v. Von Stetina, 45 So. 2d 783 (Fla.
1985); State ex reL Strykowski v. Wilkie, 81 Wis. 2d 491, 261 N.W.2d 434 (1978).
Cases in which courts have struck down such state medical malpractice statutes on consti-
tutional grounds include Kansas Malpractice Victims Coalition v. Bell, 243 Kan. 333, 757
P.2d 251 (1988) (holding that statutory provisions that require an annuity for payment of
future economic costs in all medical malpractice cases are unconstitutional because they con-
travene state constitutional guarantees of trial by jury and justice without delay); Carson v.
Maurer, 120 N.H. 925, 424 A.2d 825 (1980) (holding that statutory provisions for periodic
payment of future medical malpractice damages violated constitutional equal protection provi-
sions); Arneson v. Olson, 270 N.W.2d 125 (N.D. 1978) (not objecting to periodic payments in
general, but holding North Dakota statute unconstitutional on due process and equal protec-
tion grounds). For a thorough discussion of the constitutionality of medical malpractice stat-
utes requiring periodic payments, see Annotation, Validity of State Statute Providing for
Periodic Payment of Future Damages in Medical Malpractice Action, 41 A.L.R. 4TH 275
(1985).
208. 36 Cal. 3d 359, 683 P.2d 670, 204 Cal. Rptr. 671.
209. American Bank & Trust Co. v. Community Hospital, 104 Cal. App. 3d 219, 163 Cal.
Rptr. 513 (1980) (subsequently depublished).
210. Id. at 235, 163 Cal. Rptr. at 521.
211. American Bank & Trust Co., 36 Cal. 3d at 368, 683 P.2d at 676, 204 Cal. Rptr. at
677.
212. Id. at 369, 683 P.2d at 676, 204 Cal. Rptr. at 677.
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and the Equal Protection Clause does not prohibit the legislature from
implementing reforms one step at a time.
213
State ex rel. Strykowski v. Wilkie214 is another case in which the
court upheld the constitutionality of the state's medical malpractice stat-
ute requiring periodic payments in certain actions. The Wisconsin
Supreme Court upheld the validity of a statutory provision requiring
payment into a "future medical expenses fund" of medical malpractice
awards exceeding $25,000.215 Future medical expenses would be paid
periodically out of the fund to the plaintiff until the award were ex-
hausted or the plaintiff died.216 The court refused to apply strict scrutiny
and concluded that the legislation was neither unreasonable nor a denial
of equal protection.
217
In Carson v. Maurer21 8 the New Hampshire Supreme Court, apply-
ing a "substantial relationship" test, struck down a statute providing
that, at the request of either party, a trial court could enter a judgment
on a periodic payment basis if the award exceeded $50,000 in future dam-
ages. The court determined that the statute unreasonably discriminated
in favor of health care defendants while unduly burdening seriously in-
jured medical malpractice plaintiffs, thus violating equal protection guar-
antees.219 In reaching its holding, however, the court concentrated on
the specific provisions in the statute, and not on the general concept of
periodic payment.
220
Another constitutional consideration raised by legislation mandat-
ing periodic payments is whether the legislation invades the province of
the jury and infringes on judicial power.221 These considerations arise
213. Id. at 371, 683 P.2d at 677, 204 Cal. Rptr. at 678 (noting the prevailing sentiment
that periodic payments would eventually be mandated in all tort cases, not just medical mal-
practice cases).
214. 81 Wis. 2d 491, 261 N.W.2d 434 (1978).
215. Id. at 531,261 N.W.2d at 453 see Wis. STAT. ANN. § 655.015 (West 1980) (amended
1986).
216. Wis. STAT. ANN. § 655.015. Another provision of the statute required awards in
excess of one million dollars to be paid in maximum annual installments of $500,000. Id.
§ 655.27(5)(a).
217. Strykowski, 81 Wis. 2d at 507-13, 261 N.W. at 442-44. Three dissenters argued that
because the periodic payment provisions benefited only the insurer, the statute lacked funda-
mental fairness and violated the equal protection provisions of the U.S. and Wisconsin consti-
tutions. Id. at 540, 261 N.W. at 457. See Flora, supra note 138, at 164.
218. 120 N.H. 925, 424 A.2d 825 (1980); see HINDERT ET AL., supra note 37, § 10, at 42
(citing former N.H. REv. STAT. ANN. § 507-C:7 (IV)).
219. Carson, 120 N.H. at 944, 424 A.2d at 838.
220. See HINDERT ET AL., supra note 37, § 10, at 42 (listing the six statutory provisions
that were deemed unconstitutional by the Carson court). The court also determined that,
because the statute singled out seriously injured medical negligence victims, i.e., those with
over $50,000 in future damages, it offended basic notions of fairness and justice. Carson, 120
N.H. at 944, 424 A.2d at 838.
221. See HINDERT ET AL., supra note 37, § 10, at 45-47; Henderson, supra note 18, at 34-
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because, while the judge and jury typically enjoy substantial discretion in
calculating damages awards, some periodic payment statutes impose pre-
determined inflation factors or formulae to be applied in the calculation
of the award. 222 At least two commentators who have examined the is-
sue have determined that periodic payment statutes that are carefully
drawn will withstand constitutional challenges that they interfere with a
claimant's right to a jury trial or infringe on judicial power.223 The pre-
ceding review of cases in which the constitutionality of periodic payment
statutes was challenged illustrates that the use of periodic payments is
sufficiently important to the public interest to withstand constitutional
scrutiny.
I. The Nexus Between Medical Surveillance and Periodic
Payments
Periodic payment plans offer new opportunities for environmental
litigants generally, and toxic exposure litigants specifically.224 As a result
of an increasing number of courts recognizing medical surveillance
claims and the more frequent use of periodic payment judgments and
settlements, an individual exposed to a toxic substance is more likely to-
day to seek the creation of a medical monitoring trust fund or similar
mechanism than ever before.
A. The Periodic Payment of Medical Monitoring Expenses: A Look Back
A number of courts have ordered and approved defendant-funded
programs for medical surveillance in toxic exposure cases. 225 Other
35. See HINDERT ET AL., supra note 37, § 10, at 16-23, for a discussion of specific state provi-
sions dealing with the role of the jury and the judge in awarding periodic payments judgments.
222. See Henderson, supra note 18, at 34-35.
223. See HINDERT ET AL., supra note 37, § 10, at 48; Henderson, supra note 18, at 34
(stating that "one can convincingly argue that a legislatively determined inflation factor or
formula, applied after the verdict by the court, would not improperly invade the province of
the jury") (citation omitted).
224. See, e.g., 2 AMERICAN LAW INST., supra note 9, at 375-81 (advocating the periodic
payment of medical surveillance expenses rather than lump sum awards in toxic exposure
cases); Lawrence Cohen, Structured Settlements Applied to Environmental Claims, MICH.
LAW. WKLY., Feb. 18, 1991, at 83 (discussing an Environmental Protection Agency study
conclusion that structured settlements could promote environmental cleanup); Dennis Con-
nolly & David Miller, Structured Settlements in Environmental Litigation, FOR THE DEFENSE,
May 1990, at 2 (advocating the use of structured settlement arrangements such as medical
trust funds in toxic exposure cases).
225. See In re Agent Orange Prod. Liab. Litig., 611 F. Supp. 1396, 1399-1400 (D.C. N.Y.
1985) (approving use of fund for medically related services to Vietnam veterans and their
families suffering from Agent Orange-related ailments such as birth defects); In re Three Mile
Island Litig., 557 F. Supp. 96, 97 (M.D. Pa. 1982) (approving $5 million fund to study long-
term health effects of the Three Mile Island nuclear accident); Burns v. Jaquays Mining Corp.,
156 Ariz. 375, 381, 752 P.2d 28, 34 (1987) (entitling residents to defendant-funded program to
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courts have upheld the plaintiffs' right to pursue their medical monitor-
ing fund claims by denying defendants' motions to dismiss.
226
The New Jersey Supreme Court in Ayers v. Jackson Township set
forth a strong argument favoring court-supervised, defendant-funded
medical monitoring programs over lump sum damage awards in toxic
exposure cases.227 On appeal, the defendant, not the plaintiffs, argued
that, if the court were to uphold the jury award of medical surveillance
damages, a court-supervised fund was more appropriate than a lump sum
payment.228 The New Jersey Supreme Court, while declining to upset
the jury award of a lump sum, expressed its preference for the use of a
fund. The court highlighted the following advantages of the fund mecha-
nism when used in mass exposure cases: First, "the indeterminate nature
of damage claims in toxic-tort litigation suggests that the use of court-
supervised funds to pay medical-surveillance claims as they accrue,
rather than lump-sum verdicts, may provide a more efficient mechanism
for compensating plaintiffs." Second, a fund can provide a method for
offsetting the defendant's liability by payments from collateral sources.
Third, a fund limits the defendant's liability to the amount of expenses
actually incurred, thus preventing any monetary windfalls for the plain-
tiffs. Finally, in litigation against public entities, the fund mechanism
monitor medical condition after exposure to asbestos from adjacent mill); cf. Friends for All
Children v. Lockheed Aircraft Corp., 746 F.2d 816, 825 (D.C. Cir. 1984) (approving medical
surveillance program to monitor effects of airplane decompression on children); Ayers v. Jack-
son Township, 106 N.J. 557, 604-06, 525 A.2d 287, 312 (1987) (not disturbing lump sum jury
award of damages, but stating that, as a general rule, a court-supervised fund should be used
for medical surveillance).
226. Cook v. Rockwell Int'l Corp., 755 F. Supp. 1468 (D. Colo. 1991) (denying defend-
ants' motion to dismiss plaintiffs' claim for medical monitoring services, but dismissing plain-
tiffs' claim for general scientific studies); Cook v. Rockwell Int'l Corp., 778 F. Supp. 512 (D.
Colo. 1991) (reaffirming earlier holding that generalized population-based scientific studies are
not part of a medical monitoring cause of action, but approving plaintiffs' right to recover the
costs of pooling data derived from medical tests of exposed plaintiffs); Corron v. Koppers Co.,
No. CIVS 88-0433 (E.D. Cal. Aug. 28, 1990); Barth v. Firestone Tire & Rubber Co., 673 F.
Supp. 1466 (N.D. Cal. 1987); Habitants Against Landfill Toxicants v. City of York, [1985] 15
Envtl. L. Rep. (Envtl. L. Inst.) 20,937 (Pa. Ct. C.P. May 20, 1985).
227. 106 N.J. at 608-10, 525 A.2d at 313-14. The cases favoring a fund mechanism tend to
involve exposure by many individuals to the same deleterious substance or condition. See, eg.,
Friends for All Children, 746 F.2d 816 (action on behalf of 149 Vietnamese orphans injured in
plane crash); Barth, 673 F. Supp. 1466 (class action brought on behalf of all employees exposed
to toxic chemicals at work); In re Agent Orange, 611 F. Supp. 1396 (class action brought on
behalf of thousands of Vietnam veterans and their families, including an estimated 15,000
named plaintiffs); In re Three Mile Island, 557 F. Supp. 96 (class action on behalf of thousands
of residents within 25 mile radius of the Three Mile Island nuclear reactor); In re Fernald
Litig., No. C-01-85-0149 (S.D. Ohio 1985) (estimated 30,000 class members eligible to partici-
pate in the medical monitoring program set up by the Fernald Settlement Fund).
228. Ayers, 106 N.J. at 607, 525 A.2d at 313. Compare Barth, 673 F. Supp. at 1468, in
which the plaintiffs, not the defendants, requested the use of a fund rather than a lump sum
payment.
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will foster the legislative objective of limiting the liability of public enti-
ties. 229 According to the court, the restriction on plaintiffs' use of com-
pensatory damages was justified in mass-exposure, toxic-tort litigation
because of the public interest involved.
230
The potential benefits of periodic payment plans, in general, were
discussed previously.231 Periodic payment plans for medical surveillance
confer similar benefits on litigants, courts, and society. For example,
when an individual receives a lump sum award for future medical sur-
veillance, there is no guarantee that she, in fact, will use the money to
secure medical examinations. In contrast, a medical monitoring fund en-
sures that the money is used for medical monitoring by either reimburs-
ing the claimant for medical testing she secures on her own or by
providing her with the actual medical examinations.232
The periodic payment of medical surveillance expenses also can offer
advantages that are unique to toxic exposure cases. An example of a
unique and important function is that, when large numbers of individuals
are involved, a medical monitoring program can identify and inform in-
dividuals who were exposed to toxins but are unaware of the deleterious
health consequences. The plaintiff in Barth v. Firestone Tire & Rubber
Co., for example, envisioned a medical monitoring fund that would lo-
cate previous Firestone employees and inform them that they were ex-
posed to toxic substances during their employment.
233
Additionally, a medical monitoring fund can pool and share knowl-
edge about the health consequences of exposure to specific toxic sub-
stances. 234 This would be impractical if each exposed individual received
a lump sum because there would be no way to ensure uniform diagnostic
procedures or to collect the results.235
229. Ayers, 106 N.J. at 608-10, 525 A.2d at 314-15. The reported outcome of Ayers is that
plaintiffs were awarded medical monitoring damages in lump sums; thus, there is no guarantee
that they spent the money for medical surveillance purposes. See 2 AMERICAN LAW INST.,
supra note 9, at 379 n.59.
230. Id. No discussion was made of whether such a restriction is justified in toxic tort
cases involving fewer individuals.
231. See supra section II.D.
232. The medical monitoring program in the Fernald case, for example, provides the ac-
tual medical examinations to the plaintiffs, rather than cash payments. See infra section III.B.
233. 673 F. Supp. 1466, 1476 (N.D. Cal. 1987). At least 5000 Firestone employees were
exposed to toxic substances without their knowledge or consent from 1963 until 1981 when
Firestone closed the plant. Id. at 1468. Daniel Berger, an attorney who seeks medical moni-
toring funds on behalf of plaintiffs, advocates the notification function as an advantage of the
fund mechanism. Telephone Interview with Daniel Berger, Attorney, Berger & Montague of
Philadelphia, Pa. (Jan. 14, 1992).
234. The ALI recognized this function when it reported that "a socially beneficial role for
medical monitoring is to finance serious scientific study of the potential impact of health
hazards on exposed groups [of individuals]." 2 AMERICAN LAW INST., supra note 9, at 379.
235. A number of the specialists with whom the Author spoke supported the need for
uniformity in medical testing, particularly in mass exposure cases. Eg., Telephone Interview
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The Three Mile Island (TMI) Public Health Fund illustrates the in-
formation-gathering advantage that medical monitoring funds have over
lump sum awards for future medical expenses. A March 28, 1979 acci-
dent at the TMI nuclear power facility near Harrisburg, Pennsylvania
released radioactive material into the atmosphere. Plaintiffs began filing
lawsuits in the United States District Court for the Middle District of
Pennsylvania within days of the nuclear accident. The lawsuits sought
compensatory, punitive, and injunctive relief.23 6 The cases were joined
into one class action with three plaintiff classes. Class III consisted of
individuals living within a twenty-five-mile radius of TMI, who sought
the fair and reasonable cost of securing medical detection services to
monitor for the future manifestation of exposure-related injury.
237
A proposed settlement reached on February 17, 1981 provided for
the creation of a five million dollar Public Health Fund to finance studies
of the long-term health effects of the TMI accident and to promote evac-
uation planning for the future.238 The bulk of the settlement, twenty mil-
lion dollars, was directed toward the economic damages claims asserted
by Classes I and II, the businesses and individuals who suffered economic
loss as a result of the TMI accident. The medical component of the TMI
Public Health Fund was aimed primarily at funding objective epidemio-
logical studies, and not at providing exposed individuals with ongoing
medical screening. 239
Specifically, the February 17, 1981 Stipulation and Agreement of
Settlement stated that the Public Health Fund monies could be used for:
with H.R. Brandell, supra note 140; Telephone Interview with William T. Hayden, Special
Master/Trustee of the Fernald Settlement Fund (Oct. 31, 1991).
The Fernald Settlement Fund will not reimburse individuals for medical testing per-
formed at a facility other than the Fernald Medical Program Facility. Thus, if an individual
moves away from Fernald, she is forced to travel back to the Facility for medical testing or
forego reimbursement. According to Fernald trustee, William T. Hayden, however, individu-
als who no longer live near the Fernald Medical Program Facility will be scheduled on a
priority basis when they visit the Fernald area. Telephone Interview with William T. Hayden,
supra.
236. In re Three Mile Island Litig., 557 F. Supp. 96, 96 (M.D. Pa. 1982).
237. Id.
238. Id. at 97; see Stipulation and Agreement of Settlement at 8, Three Mile Island (No.
79-0432).
239. Telephone Interview with Daniel Berger, supra note 233; Telephone Interview with
Allan Kanner, TMI Plaintiffs' Attorney, Kanner & Assoc. of Philadelphia, Pa. (Nov. 17,
1991). Allan Kanner indicated that, while he would have liked the plaintiffs to receive peri-
odic medical testing, the defendants would not have agreed to a settlement that provided medi-
cal testing to plaintiffs. According to Mr. Berger, because the settlement agreement covered
everyone within 25 miles of the facility, and because the levels of radiation most plaintiffs were
exposed to were extremely low, it was logistically and economically impractical to institute a
medical surveillance program. Instead, settlement funds were used for epidemiological studies
to identify the incidence of radiation-related disease in the exposed population. The informa-
tion gathered from the epidemiological study might eventually be useful in other radiation
litigation.
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(b) funding of studies or analyses relating to the possible health
related effects (and related studies and analyses) resulting from the
TMI Accident and related events and approved, now or hereafter, by
the TMI Advisory Board on Health Research Studies ....
(c) funding of public education programs involving the general
public residing or working within twenty-five miles of TMI or the
medical community within or serving that region on the subjects of
[cancer and cancer detection; evacuation procedures; or public educa-
tion of any nature to reduce stress];
(e) funding general research into the effects of low level radiation
on human health and related studies and analyses. 24°
In its 1989-1990 Annual Report, the TMI Public Health Fund re-
ported the status of various research projects it had funded, including a
radiation monitoring study; a study of noble gas doses, the major radio-
active releases from the TMI accident; a study of nonradioactive but
harmful chemicals that might have been released by the accident; and an
epidemiological study.241 The results of the TMI Public Health Fund's
epidemiological study were published in the September 1990 issue of the
American Journal of Epidemiology.242 Clearly, the information gener-
ated by the various TMI Public Health Fund studies could not have been
gathered and made available to such a wide audience of scientists, medi-
cal specialists, and TMI-area residents if the TMI plaintiffs had received
individual settlement awards for medical monitoring.
Funded settlements also were used in the Love Canal and Agent Or-
ange litigations. From 1942 to 1953 Hooker Chemical and Plastics Com-
pany, now the Occidental Chemical Corporation, dumped an estimated
21,800 tons of chemicals into the Love Canal, 243 located only 1,500 feet
from the Niagara River. After Hooker sold the property to the Niagara
Falls school district in 1953, a school was built directly on top of the
waste site and a residential neighborhood sprung up around it. Over the
years, rainwater and melting snow seeped into the canal and forced
240. Stipulation and Agreement of Settlement at 13-14, Three Mile Island (No. 79-0432).
241. THREE MILE ISLAND PUBLIC HEALTH FUND, 1989-1990 ANNUAL REPORT 2-6
[hereinafter TMI ANNUAL REPORT].
242. See Hatch et al., Cancer Near the Three Mile Island Nuclear Plant: Radiation Emis-
sions, 132 AM. J. EPIDEMIOLOGY 397 (Sept. 1990). The epidemiological studies' main findings
also were set out in the TMI Public Health Fund's 1989-1990 Report as follows: There were
no statistically significant associations between exposure to accident releases or to routine
emissions from the TMI plant and the incidence of leukemia or childhood cancer; but, there
was a statistically significant trend in the TMI area for childhood cancer in relation to outdoor
background gamma radiation from cosmic and terrestrial sources. TMI ANNUAL REPORT,
supra note 241, at 11-12.
243. The canal was named after William T. Love, the 19th century industrialist who origi-
nally planned to use it as a means of transportation and a source of inexpensive hydroelectric
power. After Love abandoned his plan, the canal was used as a swimming hole by residents.
Gerald B. Silverman, Love Canal: A Retrospective, 20 Env't Rep. (BNA) 835, 836 (1989).
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chemical waste to the surface.244 The contamination spread laterally into
the yards and basements of adjoining homes, as well as into the ground
water, soil, and indoor air of homes adjacent to the canal. In 1979 state
and federal officials declared the Love Canal site an unsafe place to live
and relocated residents.245 With federal aid, the state also purchased
many of the contaminated homes from residents.
246
Current and former Love Canal residents filed several hundred per-
sonal injury and property damage cases in the state supreme court in
Niagara Falls against Occidental, as well as against the city, county, and
school board.247 The first wave of cases settled in 1983 for twenty mil-
lion dollars.248 Under the settlement process, each plaintiff was given the
opportunity to present her case to the judge before an award was made.
Support for the settlement was strong-all but seven plaintiffs backed
it.249 Under a 1983 Love Canal settlement agreement, a court allocated
awards ranging from $2000 to $400,000 per plaintiff, based on individual
injuries. The settlement also set up a one million dollar medical trust
fund to handle future medical problems.
250
In 1979 a class action was commenced charging the United States
government and a major portion of the chemical industry with deaths
and injuries to thousands of veterans who were exposed to Agent Orange
and other phenoxy herbicides in Vietnam.251 After five years of extensive
litigation, a tentative settlement was reached on the eve of trial in 1984.
The court granted final approval of the settlement in 1985.252 Of the
total two hundred million dollars remaining after payment of attorney's
fees and expenses, a class assistance foundation, initially funded at forty-
five million dollars, was organized to provide services to exposed veterans
244. Id. at 838.
245. L334 Former Love Canal Residents Receive $20 Million Under 1983 Settlement
Agreement, 15 Env't Rep. (BNA) 1445 (1985).
246. Id.
247. Besides the residents' suits on personal injury and property damage claims, the fol-
lowing litigation developed: A federal Superfund case against Occidental and other defendants
in the U.S. district court in Buffalo, New York; an insurance case filed by Occidental against
its carriers in the state supreme court in Niagara Falls; and a case filed by Occidental against
New York state in the state court of claims in Buffalo to recover any money collected by New
York in the federal Superfund action. Silverman, supra note 243, at 846.
248. Id. at 848. The first wave involved 1337 plaintiffs. The second and third waves of
cases were filed on behalf of approximately 900 new plaintiffs between 1985 and 1987. Id.
249. Id. at 849.
250. Id. Because parts of the Love Canal settlement are confidential, details about the
medical trust fund are unavailable. Telephone Interview with Richard J. Lippes, Love Canal
Plaintiffs' Attorney, Allen, Lippes & Shonn of Buffalo, N.Y. (Nov. 1, 1991). Mr. Lippes did
indicate that a trust fund board of directors was established with Love Canal residents holding
half of the positions.
251. In re Agent Orange Prod. Liab. Litig., 597 F. Supp. 740, 746 (E.D.N.Y. 1984).
252. Memorandum and Order on Attorney Fees and Final Judgment, In re Agent Orange
Prod. Liab. Litig., 611 F. Supp. 1296 (E.D.N.Y. 1985) (No. MDL 381).
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and their families, particularly to veterans with children who have birth
defects.253 To the extent feasible, financially and technically, the founda-
tion was supposed to provide grants or contract for services to meet the
health, educational, vocational, and psychological needs of class mem-
bers who filed claims with the settlement fund.254
B. The Fernald Medical Monitoring Program
More recently, a comprehensive medical surveillance program was
established pursuant to a settlement agreement in the Fernald class ac-
tion litigation.255 During the operation of the United States Department
of Energy's Feed Material Production Center in Fernald, Ohio by Na-
tional Lead of Ohio and National Lead Industries, Fernald area residents
were exposed to a variety of uranium compounds and other hazardous
substances. Plaintiffs sought an order requiring the defendants to estab-
lish a fund to pay the medical monitoring costs of all class members and
to fund epidemiological studies to determine the adverse health effects of
the radiation exposure. An advisory summary jury trial was conducted
in 1989 to facilitate pretrial settlement. The summary jury returned a
nonbinding verdict in favor of the plaintiffs, awarding them a total of one
hundred thirty-six million dollars, including eighty million dollars for a
medical monitoring fund.
256
253. In re Agent Orange, 611 F. Supp. at 1400.
254. Id. at 1441. According to Stephen J. Schlegel, the chief managing partner of the
plaintiffs' class action committee in the Agent Orange litigation, veterans can obtain free Agent
Orange physical examinations, including fat biopsies to test for dioxin concentration, from
Veterans Administration hospitals. These exams are provided pursuant to veterans' assistance
acts, not as a result of litigation. At least some veterans who underwent the Agent Orange
examinations at Veterans Administration hospitals encountered resistance when they at-
tempted to get the results of the exams. When Mr. Schlegel endeavored to obtain the physical
examination results on behalf of some of his clients, he was told that because the results are
included in the government's periodic reports, they are not released to individual veterans.
Because an important aspect of medical monitoring is the individual patient's knowledge of
whether and how the toxic exposure impacted his or her health, the Veterans Administration's
provision of free Agent Orange physical exams may be considered an incomplete remedy be-
cause the results of the exams are not released to the patients. Telephone Interview with Ste-
phen Schlegel, Attorney, Clausen, Miller, Gorman, Caffrey & Witous of Chicago, IIl. (Nov.
21, 1991).
255. The class action was originally filed on January 23, 1985 and was certified on Septem-
ber 8, 1986. One subclass contained all owners of real property within a five mile radius of the
Feed Material Production Center in Fernald, Ohio between Jan. 1, 1952 and Dec. 18, 1984. A
second subclass contained individuals who resided or worked within the five mile radius for
any continuous two year period prior to December 18, 1984. Telephone Interview with Wil-
liam T. Hayden, supra note 235.
While the plaintiff class originally was estimated to contain 14,000 individuals, that
number jumped to 30,000 when the geographic class boundary was changed from five miles
from the center of the Fernald facility to five miles from the outer boundary of the facility. Id.
256. Summary of Order at 4, In re Fernald Litig., No. C-1-85-0149 (S.D. Ohio Sept. 29,
1989).
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Under the terms of a settlement agreement which the parties
reached subsequent to the summary jury trial, the defendants agreed to
pay a total of seventy-three million dollars to the plaintiff class. The
court appointed three special masters, or trustees, to receive and manage
all of the settlement proceeds that formed the Fernald Settlement
Fund.257 The trustees were authorized to develop and administer a med-
ical monitoring program to provide class members with medical exami-
nations and to conduct epidemiological studies.
258
Pursuant to a court-approved agreement between the Fernald Settle-
ment Fund trustees and the University of Cincinnati, a pilot medical
monitoring program was conducted in September and October 1990.259
The fifty-one adult class members who participated in the pilot program
were provided with physical examinations in accordance with a court-
approved examination protocol. 26° Shortly after completion of the pilot
program, the Fernald Medical Monitoring Program was fully
implemented.
The Program provides uniform diagnostic examinations to Fernald
Settlement Fund claimants at the Fernald Program Facility at Mercy
Hospital, a Fernald area hospital. 261 Child and adolescent medical ex-
aminations are provided pursuant to a contract with Children's Hospital
Medical Center of Cincinnati. 262 The Program director provides the
Fernald Settlement Fund trustees with monthly reports and quarterly
summaries. Because the health of thousands of Fernald area residents
will be monitored at the same medical facility by the same staff and with
the same procedures, the information gathered may paint a useful picture
of the specific health consequences, if any, that result from the plaintiffs'
exposure to uranium and other toxic substances.
As of June 1991, the trustees had received more than 5600 applica-
tions to participate in the Medical Monitoring Program. 263 As of May
1991, 1175 class members had received medical examinations.264 The
Program director of the Medical Monitoring Program, Dr. Robert
Wones of the University of Cincinnati Medical Center, reported that
257. Order Appointing Special Masters/Trustees. Fernald, (No. C-1-85-0149). The Spe-
cial Masters/Trustees were Raymond R. Suskind, a medical doctor, Paul A. Nemann, an at-
torney, and J. Kermit Smith, a real property assessment specialist. William T. Hayden, an
attorney, became a trustee on August 15, 1990, following Mr. Nemann's death.
258. Id.
259. Third Report of Special Masters/Trustees Fernald (No. 1-85-0149), Dec. 19, 1990, at
2.
260. Id
261. Fourth Report of Special Masters/Trustees, Mar. 26, 1991, at 1.
262. Id. at 2.
263. Fifth Report of Special Masters/Trustees, July 25, 1991, at 1.
264. Id.
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class members were extremely satisfied with the treatment they had
received.
265
The Fernald Medical Monitoring Program illustrates that toxic ex-
posure victims who seek the periodic payment of medical surveillance
expenses can succeed. 266 The success of the Fernald Medical Monitoring
Program can be attributed to various interdependent factors. First, the
judge in the Fernald litigation recognized a claim for medical surveil-
lance, and was willing to retain jurisdiction over the Fernald Settlement
Fund. Additionally, a summary jury verdict in favor of the plaintiffs
encouraged defendants to settle promptly. The University of Cincinnati
Medical School was able to set up a special medical monitoring facility at
a hospital conveniently located in the Fernald area. Fernald plaintiffs
also overwhelmingly supported the concept of periodic medical monitor-
ing. Three very capable trustees were appointed to administer the settle-
ment fund. Finally, the trustees benefitted from consultation with legal,
265. In a June 6, 1991 Quarterly Progress Report to the trustees Dr. Wones reported that,
of the 196 satisfaction questionnaires received from class members, 129 rated the program
"excellent," 63 rated the program "very good," and 4 rated the program "good." Id. app. 1.
266. In a number of cases in which toxic exposure victims sought the creation of medical
monitoring funds, the plaintiffs eventually settled with the defendants without obtaining medi-
cal surveillance relief. For example, after the federal district court denied class certification
and remanded the case to state court for determination of state substantive issues, Barth v.
Firestone Tire & Rubber Co., 673 F. Supp. 1466 (N.D. Cal. 1987), settled on January 13, 1992
with the plaintiffs receiving no specific medical monitoring relief. Telephone Interview with
Haj Tada, Attorney, McCutcheon, Doyle, Brown & Enersen of San Francisco, Cal. (Feb. 11,
1992). The Barth court never decided the merits of the plaintiffs' medical monitoring claim.
Telephone Interview with Haj Tada, supra (Dec. 12, 1991).
The plaintiffs in Burns v. Jaquays Mining Corp., 156 Ariz. 375, 752 P.2d 28 (Ct. App.
1988), settled with the defendants in 1989, approximately ten years after the initiation of the
lawsuit. The average settlement award was $100,000 per plaintiff, with older plaintiffs receiv-
ing an average of $40,000 and younger plaintiffs receiving an average of $200,000. Although
their attorney, Mark Harrison, recommended to his clients that they use the money to set up a
medical monitoring fund, the plaintiffs opted to take their settlements in lump sums. Tele-
phone Interview with Mark Harrison, Attorney, Harrison, Harper, Christian & Dichter, of
Phoenix, Ariz. (Nov. 21, 1991). After the court denied defendants' motion to dismiss and
motion for summary judgment relating to plaintiffs' medical monitoring claims in Habitants
Against Landfill Toxicants, a confidential settlement was reached in the case. The specific
terms of the settlement are unavailable. Telephone Interview with Richard J. Lippes, supra
note 250.
The plaintiffs in the class action, Corron v. Koppers Co., No. CIVS 88.0433 (E.D. Cal.
Aug. 28, 1990), reached a tentative settlement with the defendants in September 1990. Judge
David F. Levi of the United States District Court for the Eastern District of California ap-
proved the settlement on November 1, 1991. Pursuant to the settlement agreement, plaintiffs
received a lump sum award ranging from $2500 to a maximum recovery of $15,000. After
deduction of court-awarded attorneys' fees and costs, a net settlement fund balance of $1.543
million was reported on September 24, 1991. See Notice of Plan of Allocation of Net Settle-
ment Proceeds, Sept. 24, 1991, Corron (No. CIVS-88-429 DFL/JFM); Order Approving Plan
of Allocation, Nov. 1, 1991.
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medical, and scientific experts who had been involved in prior toxic expo-
sure litigation.
IV. A Recipe for Success: The Ingredients of a Successful
Medical Monitoring Fund
The exact combination of factors that resulted in the Fernald Medi-
cal Monitoring Program will not exist in other toxic exposure cases be-
cause each case presents unique legal, medical, and scientific
circumstances. While there is no single formula for success, the Author
suggests that a careful assessment of the following considerations will
assist practitioners in seeking, implementing, and administering success-
ful medical monitoring fund programs.
A. Legal Considerations
In determining whether to seek the creation of a medical monitoring
fund, a practitioner first must determine whether her jurisdiction recog-
nizes a claim for medical surveillance. While the trend among courts
appears to support recognition, 267 at least two courts recently have re-
fused to recognize a medical monitoring tort claim.268 The practitioner's
task, of course, will be easier if her jurisdiction does recognize the claim.
A court's refusal to recognize the claim, however, does not preclude a
toxic exposure claimant from achieving a periodic medical surveillance
plan through an out-of-court settlement.
Even if the jurisdiction recognizes a medical monitoring tort claim,
judges may hold widely differing views of what constitutes "medical
monitoring." A claim for medical monitoring can encompass various
components, including, but not limited to the following: Individualized
medical monitoring of exposed claimants; scientific studies to determine
the specific effects of the toxic exposure on the exposed individuals; or
general epidemiological studies of the effects of the toxin(s) with no par-
ticular emphasis on the exposed population.2 69 The medical monitoring
267. See, eg., In re Paoli R.R. Litig., 916 F.2d 829, 850-52 (3d Cir. 1990) (holding that
Pennsylvania Supreme Court would recognize medical monitoring tort claim), cert. denied,
111 S. Ct. 1584 (1991); Cook v. Rockwell Int'l, 755 F. Supp. 1468, 1476-77 (D. Colo. 1991)
(concluding that Colorado Supreme Court would probably recognize a medical monitoring
tort claim, and stating that courts generally have accepted such claims).
268. Ball v. Joy Mfg. Co., 755 F. Supp. 1344, 1371 (S.D. W. Va. 1990) (refusing to recog-
nize medical monitoring claim in absence of ruling by state's supreme court or action by state
legislature); Potter v. Firestone Tire & Rubber Co., 225 Cal. App. 3d 213, 274 Cal. Rptr. 885)
(Cal. Ct. App. 1990) (overturning jury award for medical surveillance expenses), review
granted, 278 Cal. Rptr. 836 (1991).
269. The Fernald Settlement Fund, for instance, encompasses three distinct medical sur-
veillance components: the Medical Monitoring Program, which operates a medical testing
facility and provides eligible individuals with periodic medical examinations; a cytogenetics
program, which will determine whether there is an increase in somatic cell mutations in
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component of the Three Mile Island settlement was limited to funding
epidemiological studies and evacuation planning; there was no provision
for individualized medical testing. 270
The practitioner must determine if the relevant jurisdiction charac-
terizes medical monitoring as a claim for compensatory damages or as a
claim for equitable relief as in Barth v. Firestone Tire & Rubber Co.271 If
medical monitoring is characterized as equitable relief, the practitioner
must be prepared to present legal arguments demonstrating why her cli-
ent qualifies for equitable relief. Consequently, the practitioner must
prove that there is not an adequate legal remedy and that the plaintiff
would suffer irreparable harm if the relief were denied. 272
A practitioner next must determine whether she can meet the
threshold burden of persuading the judge to permit the plaintiffs to pur-
sue medical monitoring relief. The threshold inquiry may differ from
jurisdiction to jurisdiction. At a minimum, the practitioner should be
prepared to show a reasonable probability that her clients VAil suffer ex-
posure-related harm in the future, and that medical monitoring is reason-
ably necessary to properly diagnose the warning signs of the disease.273
A practitioner might look to a recent Third Circuit Court of Appeals
decision that set out the elements necessary to establish a medical moni-
toring claim:
1. Plaintiff was significantly exposed to a proven hazardous sub-
stance through the negligent actions of the defendant.
2. As a proximate result of exposure, plaintiff suffers a signifi-
cantly increased risk of contracting a serious latent disease.
3. That increased risk makes periodic diagnostic medical exami-
nations reasonably necessary.
Fernald area residents; and an epidemiological program to study the causes of deaths among
Fernald area residents since 1952 and to determine significant differences, if any, between the
Fernald resident population in comparison to the frequency of deaths from various causes in
the United States, in Ohio, and in the Hamilton and Butler Counties area of Ohio. See Fifth
Report of Special Masters/Trustees, July 25, 1991, In re Fernald Litig., No. C-1-85-0149 (S.D.
Ohio Sept. 29, 1989); Fourth Report of Special Masters/Trustees, Mar. 26, 1991; Third Report
of Special Masters/Trustees, Dec. 19, 1990; Second Report of Special Masters/Trustees, Sept.
23, 1990; First Report of Special Masters/Trustees, May 30, 1990. The Fernald Medical Mon-
itoring Program is limited to medical surveillance and contains no remedial provisions. If, as a
result of diagnostic exams, a Fernald claimant discovers that she has developed an exposure-
related illness, she may not recover the expenses for treating the illness from the fund. Tele-
phone Interview with William T. Hayden, supra note 235.
270. See supra notes 238-242 and accompanying text.
271. 673 F. Supp. 1466 (N.D. Cal. 1987).
272. See id. at 1477-78.
273. See In re Paoli R.R. Litig., 916 F.2d 829, 851 (3d Cir. 1990), cert denied, III S. Ct.
1584 (1991).
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4. Monitoring and testing procedures exist which make the early
detection and treatment of the disease possible and beneficial.274
Additionally, the practitioner should be prepared to present competent
expert testimony to prove these factors.275
If the practitioner prefers to litigate in federal rather than state
court, she must determine if any applicable federal statutes would permit
an exposed individual to pursue an assertedly state medical monitoring
claim in federal court. A hazardous waste case in federal court that in-
cludes CERCLA claims, for example, also may include state common
law claims.276 A plaintiff's reliance on certain statutes, however, may
either help or hinder her medical monitoring claim. For instance, in the
federal jurisdictions that have recognized medical surveillance costs as
necessary response costs under CERCLA, 277 the practitioner should as-
sert a medical monitoring claim under CERCLA, as well as under com-
mon law principles. The practitioner should be wary, however, that
CERCLA provides opportunities to mire a medical monitoring claim in
technical legal arguments. 278 Other statutes, such as workers' compensa-
tion statutes, also provide opportunities for sidetracking medical moni-
toring fund claims. A plaintiff's attorney should be prepared to prove
that the statute in question does not provide a medical monitoring fund
remedy and, therefore, does not preempt the medical monitoring
claim.
27 9
An attorney who represents toxic exposure victims might consider
requesting provisional relief from the party or parties whose conduct re-
sulted in the release of toxic substances. This type of relief, if granted,
274. lId at 852 (citing Merry v. Westinghouse Elec. Corp., 684 F. Supp. 847 (M.D. Pa.
1988)).
275. Id. (citing Ayers v. Jackson Township, 106 N.J. 557, 606, 525 A.2d 287, 312 (1987)).
276. See, eg., Cook v. Rockwell Int'l Corp., 755 F. Supp. 1468 (D. Colo. 1991) (plaintiffs
seeking medical monitoring claim under CERCLA and state common law); Werlein v. United
States, 746 F. Supp. 887 (D. Minn. 1990) (plaintiffs seeking relief under three federal environ-
mental statutes and under state common law).
277. See supra notes 65-67 and accompanying text.
278. For instance, Daniel Berger, who has pursued numerous medical monitoring funds
on behalf of plaintiffs, has seen defense attorneys make a variety of technical legal arguments,
such as arguing that CERCLA preempts state common law claims or that CERCLA prevents
private common law actions while the federal cleanup is underway. These arguments rarely
succeed but do serve to delay the litigation. Telephone Interview with Daniel Berger, supra
note 233 (Nov. 21, 1991).
279. Telephone Interview with Peter Kunstler, Attorney, Century City, California (Janu-
ary 9, 1992). In discussing Barth v. Firestone Tire & Rubber Co., 673 F. Supp. 1466 (N.D.
Cal. 1987), Mr. Kunstler indicated that the major sticking point was California Labor Code
§ 3602 (West 1989), the exclusivity provision of the California workers' compensation statute.
According to Mr. Kunstler, if the toxic exposure occurred at the workplace, the employer will
always assert a workers' compensation exclusivity argument, which forces the plaintiff employ-
ees to prove that medical monitoring is not a remedy covered under the workers' compensation
statute. Id
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would provide immediate medical monitoring services to exposure vic-
tims prior to the conclusion of a lawsuit. Courts usually are reluctant to
order defendants to provide relief to plaintiffs prior to the conclusion of a
lawsuit, but some precedent does exist. For instance, in Friends for All
Children v. Lockheed Aircraft Corp.,280 the court granted the plaintiff's
request for a mandatory preliminary injunction requiring the defendant
to create a fund to pay for diagnostic examinations. If the incident that
caused the release of toxic substances is widely publicized, the responsi-
ble party might voluntarily provide provisional relief to avoid a public
relations debacle. An example of this is the Southern Pacific Railroad's
voluntary payment of out-of-pocket medical expenses for people who suf-
fered ill effects, such as difficulty breathing and skin irritations, from the
chemical spill that devastated California's upper Sacramento River in
July 1991.281
B. Medical and Scientific Considerations
The scope of relief is necessarily a medical and scientific issue that
should be determined by medical and scientific experts.282 To determine
the appropriate scope of relief, experts must assess a plethora of factors
including, but not limited to, the following: The nature of the toxins to
which the plaintiffs were exposed; the known or suspected health effects
of the toxins; the nature of the potential exposure-related diseases; and
the chance that early detection will benefit the exposure victim.
The circumstances of each case will directly influence medical and
scientific determinations. For example, a full scale medical surveillance
program may not prove necessary if medical experts and scientists deter-
mine that the levels of exposure were too slight to pose serious health
risks. Alternatively, a preliminary health study of the exposed popula-
tion might identify critical subgroups who would benefit the most from
periodic medical screening. When the Hawaii milk supply was tainted
with the chemical heptachlor in the early 1980s, the babies of women
280. 746 F.2d 816, 831 (D.C. Cir. 1984) (holding that preliminary injunction requiring
defendant to create medical monitoring fund was proper when delay inherent in trying the case
would result in irreparable injury).
281. Dennis Pfaff, In the Railroad Spill's Wake Come Counsel Conducting a Health Sur-
vey, S.F. DAILY J., Sept. 6, 1991, at 1, 6.
282. Cook v. Rockwell Int'l Corp., 755 F. Supp. 1468 (D. Colo. 1991), illustrates the con-
fusion that results when judges try to rule on these types of medical and scientific issues. Judge
Babcock first held that a medical monitoring claim compensates plaintiffs for diagnostic treat-
ment and "does not compensate a plaintiff for testing others to determine the odds that a
particular person might contract a disease." Id. at 1478. Nine months later, after reconsider-
ing the issue, Judge Babcock reaffirmed his holding that "generalized population based scien-
tific studies are not cognizable in a medical monitoring cause of action," but held that a
population-based health study would be considered part of a medical monitoring claim as long
as it was limited to pooling the data derived from the medical tests of exposed plaintiffs. Cook,
778 F. Supp. 513, 514 (D. Colo. 1991).
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who drank the contaminated milk faced an increased risk of birth de-
fects. A number of studies, including one funded by a multimillion dol-
lar class action settlement, specifically investigated the health effects of
heptachlor on the at-risk population.
283
Another important medical and scientific consideration is whether
early detection of an exposure-related disease will benefit the claimant.
For instance, if breast cancer could result from the toxic exposure, then a
medical monitoring fund will benefit the claimant because early detection
improves the prospects for treating breast cancer.284 On the other hand,
if the exposed claimant risks lung cancer, then medical experts might
discount the value of periodic medical exams on the belief that the pros-
pects for treating lung cancer, even when detected at an early stage, are
slim. 28
5
Lawyers and judges must rely on medical experts and scientists to
determine how frequently the exposed individuals should be tested and
what diagnostic procedures are warranted. For example, in Burns v. Ja-
quays Mining Corp.,286 the plaintiffs' medical expert, Dr. Michael Gray,
testified that the surveillance should include physical exams, blood and
urine tests, electrocardiograms, periodic chest x-rays, CT scanning tech-
niques, and/or magnetic resonance imaging and pulmonary function
testing. Dr. Gray also recommended periodic rectal and gastrointestinal
exams for individuals who were over age forty at the time of their initial
exposure to asbestos. 287 The University of Cincinnati Medical School
submitted a protocol for the Fernald Medical Monitoring Fund, which
was approved by the court and subsequently implemented. 288 The proto-
col provides for a two part comprehensive medical history and initial
physical examination of all eligible and interested adults,289 including
blood and urine tests, chest x-rays, EKG's, spirograms, pap smears,
mammograms, and an examination of all organ systems.
C. Practical and Administrative Considerations
Like the medical and scientific considerations, the number and vari-
ety of practical and administrative considerations appear limitless be-
cause of the unique circumstances of each case and the unique needs of
283. See 1 AMERICAN LAW INST., supra note 9, at 327 n.69; Gara, supra note 7, at 299. A
University of Hawaii researcher discovered a rise in birth defects among babies of women who
drank the contaminated milk. Ronald A. Taylor, Is the Food You Eat Dangerous to Your
Health?, U.S. NEws & WORLD REP., July 15, 1985, at 64.
284. Telephone Interview with Allan Kanner, supra note 239.
285. Id.
286. 156 Ariz. 375, 380, 752 P.2d 28, 33 (Ct. App. 1988).
287. Id.
288. A copy of the Medical Monitoring Program Protocol is on file at the Hastings Law
Journal office in San Francisco, Cal.
289. Separate medical monitoring procedures were set out for children.
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individual toxic exposure victims. A major factor in determining the fea-
sibility of and designing a medical monitoring program is the number of
exposed individuals and the number of defendants. If large numbers of
individuals are involved, judges might favor a formal medical monitoring
program for administrative efficiency. For example, the Fernald Medical
Monitoring Fund services a plaintiff class estimated at thirty thousand
members; the sheer number justifies the appointment of three Special
Masters/Trustees and the maintenance of a fully equipped medical facil-
ity with full-time medical staff, an extensive computer system, and com-
munity outreach capabilities. 290 This type of comprehensive medical
program simply would not be feasible with a smaller group of claimants.
That is not to say, however, that medical monitoring funds are possible
only in mass exposure cases. If the exposure affected smaller groups of
individuals, less extensive medical monitoring funds still may be imple-
mented. 291 Rather than maintaining a full-time medical staff to provide
examinations, for example, a more modest medical monitoring plan
might provide claimants with references to specific medical facilities and
then reimburse the claimants for the cost of the exams.
Additional practical and administrative considerations include what
form the medical monitoring fund should take and who should supervise
it. If a court is involved, the judge may wish to appoint a trustee to
administer the fund. The judge may appoint a magistrate to address
questions as they arise, or she may wish to remain directly involved in
supervising the fund. If children are involved, a judge may order the
creation of a special trust fund or conservatorship to protect the money
and ensure that the children receive the proper medical exams. If the
medical monitoring award is a result of a private out-of-court settlement,
the defendant might purchase an annuity to fund the plaintiff's future
medical exams.
Provisions will have to be made regarding how long the medical
monitoring fund is to operate, and what happens to the remaining
money, if any, at the time the fund terminates. The advice of medical
experts might be useful in determining the length of time a fund should
operate. For instance, if the exposure-related disease for which the ex-
ams test is known to manifest itself within twenty-five years of exposure,
testing beyond that time period may not be medically necessary.
Medical economists can estimate the cost of future medical services
so that judges and practitioners can ensure that a sufficient amount of
290. See Fifth Report of Special Masters/Trustees, July 25, 1991, In re Fernald Litig., No.
C-1-85-0149 (S.D. Ohio Sept. 29, 1989); Fourth Report of Special Masters/Trustees, Mar. 26,
1991; Third Report of Special Masters/Trustees, Dec. 19, 1990; Second Report of Special
Masters/Trustees, Sept. 23, 1990; First Report of Special Masters/Trustees, May 30, 1990.
291. H.R. Brandell, a structured settlement specialist, believes that an effective periodic
payment plan for medical monitoring is possible even if only one or two individuals are in-
volved. Telephone Interview with H.R. Brandell, supra note 140.
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"seed money" is obtained for the fund. Then, a trustee or fund adminis-
trator can take responsibility for managing the fund assets. The Fernald
Settlement Fund trustees invested the money in short term United States
Treasury bills, notes, and other obligations secured by the United States
Government. They also established the Fernald Medical Foundation,
Inc., a tax exempt trust pursuant to Section 501(c) of the Internal Reve-
nue Code to fund the Medical Monitoring Program.292 The tax exempt
status will result in direct cash savings to the plaintiff class.293
D. The Human Factor
The individual needs and characteristics of toxic exposure victims
are perhaps the most important factors for judges and attorneys to con-
sider. If the exposed individual opposes the concept of periodic medical
monitoring, or simply lacks enthusiasm for the idea, then even the most
dedicated counsel will have difficulty convincing her client that a medical
monitoring plan is superior to a lump sum award. According to one
practitioner, exposure victims are like alcoholics and drug users in that
they often deny that their health is at risk and that they need assist-
ance.294 Other practitioners cite the fact that given the choice between a
lump sum award for medical monitoring or the creation of a medical
monitoring fund, most will opt for the lump sum even if it is discounted
to present value.295
The age of the exposure victim may determine whether a medical
monitoring fund claim will be successful. For example, judges might be
more likely to approve of a fund mechanism if children are involved.
Exposed parents with small children might be more supportive of an
ongoing fund mechanism if they believe their children's health will be
better cared for with a medical monitoring fund than with a lump sum
award. Older individuals might be more likely to prefer a lump sum
because the long latency periods of exposure-related diseases mean that
an older person will benefit less from early diagnosis than a younger per-
son. The fact that many older individuals live on fixed incomes might
influence them to reject periodic payments in favor of a lump sum that
292. Fourth Report of Trustees, Mar. 26, 1991, at 8, In re Fernald Litig., No. C-1-85-0149
(S.D. Ohio Sept. 29, 1989).
293. Id. at 8-9.
294. Telephone Interview with Mark Harrison, supra note 266. Mr. Harrison represented
plaintiffs in Burns v. Jaquays Mining Corp., 156 Ariz. 375, 752 P.2d 28 (Ct. App. 1988),
litigation.
295. Telephone Interview with Mark Harrison, supra note 266 (stating that, although he
recommended a medical monitoring fund to his clients, they opted for a lump sum award);
contra Telephone Interview with Richard J. Lippes, supra note 250 (stating that parents of
young children and more sophisticated plaintiffs might prefer a medical monitoring fund to a
lump sum award).
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they can enjoy while they are alive. Practitioners must carefully consider
these and other factors when litigating medical monitoring fund claims.
Conclusion
For many Americans, exposure to toxic substances has become a
sad reality of life. The medical and scientific communities already have
recognized the need for presymptom, postexposure medical diagnosis to
detect and treat exposure-related diseases as soon as possible. The legal
community has responded more slowly to the problems faced by toxic
exposure victims. Most of the courts that recently have ruled on claims
for medical surveillance, however, have recognized the value of pos-
texposure, presymptom medical surveillance. Recognition of this claim
by all courts would go a long way toward healing the wounds inflicted
when individuals are unwittingly exposed to toxic substances.
While the lump sum award is the most common method for paying
damages awards in both the settlement and judgment contexts, the peri-
odic payment of medical surveillance expenses through the use of court-
supervised, defendant-funded programs is preferable in certain cases. A
practitioner must carefully weigh legal, medical and scientific, practical
and administrative, and human considerations in determining whether
her client will benefit from the creation of a medical monitoring fund or
comparable periodic payment mechanism.
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